UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
||||||
FORM
10-K
|
||||||
x ANNUAL REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For
the fiscal year ended April 30, 2009
or
¨ TRANSITION REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For
the transition period from
___________ to ___________
Commission
file number: 1-5865
|
||||||
Gerber
Scientific, Inc.
(Exact
name of registrant as specified in its charter)
|
||||||
Connecticut
(State
or other jurisdiction of incorporation or organization)
|
06-0640743
(I.R.S.
Employer Identification No.)
|
|||||
83
Gerber Road West, South Windsor, Connecticut
(Address
of principal executive offices)
|
06074
(Zip
Code)
|
|||||
Registrant's
telephone number, including area code: (860)
644-1551
|
||||||
Securities
registered pursuant to Section 12(b) of the Act:
|
||||||
Title of each
class
|
Name of each exchange
on which registered
|
|||||
Common
Stock, par value $0.01 per share
|
New
York Stock Exchange
|
|||||
Securities
registered pursuant to Section 12(g) of the
Act: None
|
||||||
Indicate
by check mark if the registrant is a well-known seasoned issuer, as
defined in Rule 405 of the Securities Act. Yes ¨ No
þ
|
||||||
Indicate
by check mark if the registrant is not required to file reports pursuant
to Section 13 or Section 15(d) of the Act. Yes ¨ No
þ
|
||||||
Indicate
by check mark whether the registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.
Yes þ No
¨
|
||||||
Indicate
by check mark whether the registrant has submitted electronically and
posted on its corporate Website, if any, every Interactive Data File
required to be submitted and posted pursuant to Rule 405 of Regulation S-T
during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such
files). Yes ¨ No
¨
|
||||||
Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of
Regulation S-K is not contained herein, and will not be contained, to the
best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K. o
|
||||||
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting
company. See the definitions of "large accelerated filer,"
"accelerated filer" and "smaller reporting company" in Rule 12b-2 of the
Exchange Act.
Large
accelerated filer ¨ Accelerated
filer þ Non-accelerated
filer ¨ Smaller
reporting company ¨
|
||||||
Indicate
by check mark whether the registrant is a shell company (as defined in
Rule 12-b2 of the Act.) Yes ¨ No
þ
|
||||||
The
aggregate market value of Gerber Scientific, Inc. common stock held by
non-affiliates as of October 31, 2008, which was the last business day of
the registrant's most recently completed second quarter, based on the
reported closing price of the common stock on the New York Stock Exchange
on such date, was approximately $111,643,198.
|
||||||
24,608,644
shares of common stock of the registrant were outstanding as of June 30,
2009, exclusive of treasury shares.
|
||||||
Documents incorporated by
reference: None
|
||||||
GERBER
SCIENTIFIC, INC.
Index
to Annual Report
on
Form 10-K
Fiscal
Year Ended April 30, 2009
|
||||||
PART
I
|
PAGE
|
|||||
Item
1.
|
4-15
|
|||||
Item
1A.
|
15-22
|
|||||
Item
1B.
|
22
|
|||||
Item
2
|
22
|
|||||
Item
3.
|
23
|
|||||
Item
4.
|
23
|
|||||
24
|
||||||
PART
II
|
||||||
Item
5.
|
25-27
|
|||||
Item
6.
|
27
|
|||||
Item
7.
|
28-45
|
|||||
Item
7A.
|
45
|
|||||
Item
8.
|
45
|
|||||
Item
9.
|
45
|
|||||
Item
9A.
|
46
|
|||||
Item
9B.
|
46-47
|
|||||
PART
III
|
||||||
Item
10.
|
48-49
|
|||||
Item
11.
|
50-71
|
|||||
Item
12.
|
71-74
|
|||||
Item
13.
|
75
|
|||||
Item
14.
|
75-76
|
|||||
PART
IV
|
||||||
Item
15.
|
77-112
|
|||||
113
|
For
the fiscal year ended April 30, 2009
|
|||||||||
Operating
Segment
|
Principal
Business Unit(s)
|
Revenue
(in
millions)
|
Percent
of
Revenue
|
||||||
Sign
Making and Specialty Graphics
|
Gerber
Scientific Products and Spandex
|
$
|
320.7
|
58
|
%
|
||||
Apparel
and Flexible Materials
|
Gerber
Technology
|
174.6
|
32
|
%
|
|||||
Ophthalmic
Lens Processing
|
Gerber
Coburn
|
57.5
|
10
|
%
|
|||||
$
|
552.8
|
100
|
%
|
·
|
conceptual
design, advanced CAD pattern-making, and marking or nesting
software;
|
·
|
pattern
design digitizers and large format
plotters;
|
·
|
CAM
material spreading and single- and multi-ply cutting
systems;
|
·
|
product
lifecycle management, or "PLM," and product data management, or "PDM,"
software, which are enterprise-wide applications used by apparel brands
and retailers for global management of product activities and which
facilitate communication of measurement specifications, construction
details, costing and bill of material information among apparel and other
flexible materials designers, raw materials suppliers, makers of the
materials and retailers;
|
·
|
precision
laser-based templating, inspection, marking and engraving
solutions;
|
·
|
aftermarket
supplies, including spare parts and consumable materials;
and
|
·
|
customer
training, technical support and comprehensive maintenance and specialized
support services.
|
Apparel
and retail
|
57
|
%
|
||
Industrial
and aerospace composites
|
27
|
%
|
||
Transportation
interiors
|
10
|
%
|
||
Furniture
|
6
|
%
|
April
30,
|
||||||||
In
thousands
|
2009
|
2008
|
||||||
Sign
Making and Specialty Graphics
|
$
|
1,967
|
$
|
3,462
|
||||
Apparel
and Flexible Materials
|
22,894
|
33,770
|
||||||
Ophthalmic
Lens Processing
|
1,200
|
1,440
|
||||||
$
|
26,061
|
$
|
38,672
|
·
|
the
pursuit of ultimately unconsummated acquisitions and the integration of
acquired businesses could significantly strain management, financial and
other resources and divert limited resources from regular
operations;
|
·
|
acquisitions
may not have an immediate positive impact on Gerber's cash flows or
results of operations due to transaction-related expenses or higher
operating and administrative expenses that may be incurred during the
integration period immediately following the
acquisitions;
|
·
|
Gerber
may not be able to achieve the synergies and cost savings anticipated to
result from any acquisition;
|
·
|
Gerber's
operating and financial systems and controls and information services may
not be compatible with those of acquired companies or adequate to support
integration efforts and any steps taken to improve these systems and
controls may not be sufficient;
|
·
|
acquisitions
could increase Gerber's need for qualified personnel, who may not be
available; and
|
·
|
acquired
businesses may have unexpected liabilities and contingencies, which could
be significant.
|
·
|
general
geopolitical risks, such as political and economic instability and changes
in diplomatic and trade
relationships;
|
·
|
imposition
of or increases in currency exchange
controls;
|
·
|
potential
inflation in the applicable foreign
economies;
|
·
|
imposition
of or increases in import duties and other tariffs on products;
and
|
·
|
imposition
of or increases in foreign taxation of earnings and withholding on
payments received from
subsidiaries.
|
·
|
make
it more difficult for Gerber to satisfy its financial
obligations;
|
·
|
require
Gerber to dedicate a substantial portion of its cash flow from operations
to payments on its indebtedness;
|
·
|
limit
Gerber’s ability to react to changes to the economy or in its business or
industry; and
|
·
|
place
Gerber at a competitive disadvantage relative to companies that have less
indebtedness.
|
·
|
incur
additional indebtedness, create liens and make
investments;
|
·
|
pay
dividends on or redeem or repurchase capital stock, and issue or sell
stock of subsidiaries; and
|
·
|
engage
in sale-leaseback transactions, sell assets and engage in mergers, sales,
acquisitions and consolidations.
|
·
|
changes
in general economic conditions and specific conditions in industries in
which Gerber's businesses operate that can result in the deferral or
reduction of purchases by end-use
customers;
|
·
|
changes
in the level of global corporate spending on technologies due to such
economic conditions;
|
·
|
the
effects of terrorist activity and international conflicts, which could
lead to business interruptions;
|
·
|
the
size and timing of significant orders, which can be
non-recurring;
|
·
|
product
configuration and mix;
|
·
|
market
acceptance of new products and product
enhancements;
|
·
|
announcements,
introductions and transitions of new products by Gerber or Gerber's
competitors;
|
·
|
deferrals
of customer orders in anticipation of new products or product enhancements
introduced by Gerber or Gerber's
competitors;
|
·
|
changes
in pricing in response to competitive pricing
actions;
|
·
|
supply
constraints;
|
·
|
the
level of expenditures on research and development and sales and marketing
programs;
|
·
|
Gerber's
ability to achieve targeted cost
reductions;
|
·
|
rising
interest rates; and
|
·
|
costs
associated with excess capacity and/or idle
facilities.
|
Type
of Facility
|
Location
|
Square
Feet
|
|
Corporate
headquarters / manufacturing / office (L) (1,3)
|
South
Windsor, Connecticut
|
250,000
|
|
Manufacturing
/ office (O) (1,2,3)
|
Tolland,
Connecticut
|
224,000
|
|
Manufacturing
/ office (L) (4)
|
Manchester,
Connecticut
|
118,000
|
|
Manufacturing
/ office (O) (1)
|
Lancaster,
England
|
125,000
|
|
Manufacturing
/ office (L) (2)
|
Ikast,
Denmark
|
39,000
|
|
Manufacturing
/ office (O) (1)
|
Achern,
Germany
|
56,000
|
|
Warehouse
/ sales and service office (L) (1,4)
|
Bristol,
England
|
110,000
|
|
Manufacturing
/ warehouses / sales and service offices (L) (1,2,3)
|
Various
|
653,000
|
|
(O)
|
Company-owned
|
||
(L)
|
Leased
|
||
(1)
|
Sign
Making and Specialty Graphics
|
||
(2)
|
Apparel
and Flexible Materials
|
||
(3)
|
Ophthalmic
Lens Processing
|
||
(4)
|
As
of April 30, 2009, the Company sublet 6,505 square feet in Manchester,
Connecticut and 45,145 square feet in Bristol, England to independent
third parties. These subleases expire over various
periods.
|
Name
|
Age
|
Position
as of April 30, 2009
and
Date of Initial Appointment
|
Other
Business Experience Since April 30, 2004
|
Marc
T. Giles
|
53
|
President
and Chief Executive Officer (November 29, 2001)
|
---
|
Michael
R. Elia
|
50
|
Executive
Vice President and Chief Financial Officer (April 15,
2008)
|
Chief
Financial Officer, Risk Management Solutions, Inc. (January 2008 – April
2008), a specialty service provider for the insured and alternative risk
marketplace; Senior Vice President and Chief Financial Officer of
FastenTech, Inc. (January 2004 - December 2007), a global metal products
manufacturer; Owner, private financial and marketing services consulting
company (May 2003 - December 2004)
|
James
S. Arthurs
|
65
|
Senior
Vice President (September 30, 2002); President Asia-Pacific, Gerber
Scientific, Inc. (February 1, 2005)
|
President,
Gerber Technology (September 2002 - January 2005)
|
William
V. Grickis, Jr.
|
58
|
Senior
Vice President and General Counsel (October 1, 2003); Secretary (November
20, 2003)
|
---
|
John
R. Hancock
|
62
|
Senior
Vice President (December 7, 2001); President, Gerber Technology (February
1, 2005)
|
President,
Gerber Coburn Optical (December 2001 - February 2005)
|
Alex
F. Incera
|
45
|
President,
Gerber Coburn (September 25, 2008)
|
General
Manager, Gerber Coburn (January 2008 – September 24, 2008); Executive
Director of Marketing, Gerber Coburn (October 2006 – January 2008); Vice
President of Engineering, Gerber Coburn (March 1999-October
2006)
|
John
J. Krawczynski
|
37
|
Vice
President, Chief Accounting Officer and Corporate Controller (September 5,
2005)
|
Controller,
Lydall, Inc. (May 2004 - August 2005), manufacturer of thermal/acoustical
and filtration/separation products
|
Rodney
W. Larson
|
51
|
Senior
Vice President (May 1, 2007); President, Spandex (July 1,
2007)
|
President,
Gerber Coburn (March 2006 – July 2007); Independent consultant (2005 –
April 2007); VP, Sales and Marketing, Key Technology (2003 - 2005),
developer of automated inspection, sorting and material conveying
solutions for process industries
|
Stephen
P. Lovass
|
39
|
Senior
Vice President; President, Gerber Scientific Products (February 11,
2008)
|
President,
Gerber Coburn (July 1, 2007 – September 24, 2008); Vice President;
President, Spandex (November 2006); Interim Group Managing Director,
Spandex (February 2005 - November 2006); VP, Marketing and
Business Development, Spandex (April 2004 - February
2005)
|
Joseph
R. Mele
|
57
|
Senior
Vice President, Operations (January 2, 2008)
|
Partner,
Lean Horizons Consulting (January 2006 - December 2007); Partner,
Accenture (February 1998 – December 2005), global management consulting,
technology services and outsourcing company
|
Jay
Wickliff 1
|
57
|
Vice
President; Global Human Resources (September 1, 2006)
|
Executive
Director, Human Resources (January 2002 - September
2006)
|
High
|
Low
|
Close
|
||||||||||
Fiscal
2009
|
||||||||||||
First
Quarter
|
$
|
12.64
|
$
|
8.74
|
$
|
11.87
|
||||||
Second
Quarter
|
$
|
12.00
|
$
|
4.18
|
$
|
4.78
|
||||||
Third
Quarter
|
$
|
5.50
|
$
|
1.79
|
$
|
3.14
|
||||||
Fourth
Quarter
|
$
|
3.98
|
$
|
1.65
|
$
|
3.95
|
||||||
Fiscal
2008
|
||||||||||||
First
Quarter
|
$
|
13.25
|
$
|
9.76
|
$
|
10.38
|
||||||
Second
Quarter
|
$
|
11.94
|
$
|
9.74
|
$
|
11.05
|
||||||
Third
Quarter
|
$
|
11.24
|
$
|
8.25
|
$
|
8.80
|
||||||
Fourth
Quarter
|
$
|
9.68
|
$
|
7.56
|
$
|
9.27
|
Period
|
(a)
Total
Number
of
Shares
(or
Units)
Purchased
|
(b)
Average
Price
Paid
per
Share
(or
Unit)
|
(c)
Total
Number of
Shares
(or Units)
Purchased
as Part
of
Publicly
Announced
Plans
or
Programs
|
(d)
Maximum
Number
(or
Approximate
Dollar
Value)
of
Shares (or Units)
that
May Yet Be
Purchased
Under the
Plans
or Program
|
||||||
February
1, 2009 – February 28, 2009
|
---
|
---
|
Not
applicable
|
Not
applicable
|
||||||
March
1, 2009 – March 31, 2009 (1)
|
331
|
$ |
1.87
|
Not
applicable
|
Not
applicable
|
|||||
April
1, 2009 – April 30, 2009
|
---
|
---
|
Not
applicable
|
Not
applicable
|
||||||
331
|
$ |
1.87
|
Not
applicable
|
Not
applicable
|
Apr-04
|
Apr-05
|
Apr-06
|
Apr-07
|
Apr-08
|
Apr-09
|
|||||||||||||||||||
Gerber
Scientific, Inc.
|
100.00 | 118.00 | 172.83 | 166.83 | 154.50 | 65.83 | ||||||||||||||||||
S&P
Smallcap 600
|
100.00 | 110.43 | 145.10 | 156.19 | 142.07 | 99.37 | ||||||||||||||||||
Dow
Jones US Electronic Equipment
|
100.00 | 95.62 | 133.48 | 141.65 | 147.81 | 101.59 |
For
the Fiscal Years Ended April 30,
|
||||||||||||||||||||
In
thousands except per share amounts
|
2009
|
2008
|
2007
|
2006
|
2005
|
|||||||||||||||
Revenue
|
$
|
552,814
|
$
|
640,017
|
$
|
574,798
|
$
|
530,418
|
$
|
517,322
|
||||||||||
Income
(loss) before cumulative effect of a change in
accounting
principle
|
$
|
2,236
|
$
|
14,504
|
$
|
13,508
|
$
|
2,984
|
$
|
(5,638
|
)
|
|||||||||
Per
common share:
|
||||||||||||||||||||
Basic
|
$
|
0.09
|
$
|
0.62
|
$
|
0.59
|
$
|
0.13
|
$
|
(0.25
|
)
|
|||||||||
Diluted
|
$
|
0.09
|
$
|
0.61
|
$
|
0.58
|
$
|
0.13
|
$
|
(0.25
|
)
|
|||||||||
Net
income (loss)
|
$
|
2,236
|
$
|
14,504
|
$
|
13,508
|
$
|
2,644
|
$
|
(5,638
|
)
|
|||||||||
Per
common share:
|
||||||||||||||||||||
Basic
|
$
|
0.09
|
$
|
0.62
|
$
|
0.59
|
$
|
0.12
|
$
|
(0.25
|
)
|
|||||||||
Diluted
|
$
|
0.09
|
$
|
0.61
|
$
|
0.58
|
$
|
0.12
|
$
|
(0.25
|
)
|
|||||||||
Total
assets
|
$
|
359,217
|
$
|
378,539
|
$
|
335,962
|
$
|
310,480
|
$
|
313,319
|
||||||||||
Long-term
debt (includes current maturities)
|
$
|
73,500
|
$
|
42,000
|
$
|
31,836
|
$
|
37,120
|
$
|
45,742
|
||||||||||
Shareholders'
equity
|
$
|
148,302
|
$
|
169,563
|
$
|
144,481
|
$
|
125,616
|
$
|
115,715
|
·
|
expected
financial condition, future earnings, levels of growth, or other measures
of financial performance, or the future size of market segments or
geographic markets;
|
·
|
economic
conditions;
|
·
|
planned
cost reductions;
|
·
|
future
cash flows and uses of cash and debt reduction
strategies;
|
·
|
prospective
product developments and business growth opportunities, as well as
competitor product developments;
|
·
|
demand
for Gerber's products and services;
|
·
|
methods
of and costs associated with potential geographic
expansion;
|
·
|
regulatory
and market developments and the impact of such developments on future
operating results;
|
·
|
potential
impacts from credit market risk;
|
·
|
future
effective income tax rates;
|
·
|
the
outcome of contingencies;
|
·
|
the
availability and cost of raw materials;
and
|
·
|
pension
plan assumptions and future
contributions.
|
·
|
Overview and Outlook -
a brief summary of fiscal 2009 results and trends and expectations for
future periods.
|
·
|
Results of Operations
and Segment
Review - an analysis of Gerber's consolidated results of operations
for the three years presented in the consolidated financial statements and
by reportable segment.
|
·
|
Financial Condition -
an analysis of Gerber's liquidity and capital resources, cash flows,
off-balance sheet arrangements, aggregate contractual obligations, and an
overview of the financial position.
|
·
|
Critical Accounting Estimates
- a description of accounting policies that require critical
judgment and estimates.
|
·
|
Sign
Making and Specialty Graphics (Gerber Scientific Products and Spandex
business units);
|
·
|
Apparel
and Flexible Materials (Gerber Technology);
and
|
·
|
Ophthalmic
Lens Processing (Gerber Coburn).
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
In
thousands
|
2009
|
2008
|
2007
|
|||||||||
Sign
Making and Specialty Graphics
|
$
|
320,705
|
$
|
361,086
|
$
|
302,087
|
||||||
Apparel
and Flexible Materials
|
174,566
|
207,945
|
196,164
|
|||||||||
Ophthalmic
Lens Processing
|
57,543
|
70,986
|
76,547
|
|||||||||
Revenue
|
$
|
552,814
|
$
|
640,017
|
$
|
574,798
|
For
the Fiscal Years Ended April 30,
|
|||||||||||||||
2009
|
2008
|
2007
|
|||||||||||||
Gross
profit margin
|
27.9 | % | 29.1 | % | 30.0 | % | |||||||||
Selling,
general and administrative ("SG&A") expenses
|
(22.7 | ) | % | (21.1 | ) | % | (21.7 | ) | % | ||||||
Research
and development
|
(4.1 | ) | % | (4.1 | ) | % | (4.2 | ) | % | ||||||
Operating
income
|
1.1 | % | 3.9 | % | 4.1 | % |
For
the Fiscal Years Ended April 30,
|
||||||||||||
In
thousands
|
2009
|
2008
|
2007
|
|||||||||
Revenue
|
$
|
552,814
|
$
|
640,017
|
$
|
574,798
|
||||||
Cost
of sales
|
398,436
|
453,484
|
402,424
|
|||||||||
Gross
profit
|
154,378
|
186,533
|
172,374
|
|||||||||
Selling,
general and administrative expenses
|
125,726
|
135,297
|
124,460
|
|||||||||
Research
and development
|
22,417
|
26,187
|
24,282
|
|||||||||
Operating
income
|
$
|
6,235
|
$
|
25,049
|
$
|
23,632
|
For
the Fiscal Years Ended April 30,
|
||||||||||||||||||
In
thousands
|
2009
|
2008
|
2007
|
|||||||||||||||
Equipment
and software revenue
|
$ | 159,505 | 29 | % | $ | 205,180 | 32 | % | $ | 192,166 | 33 | % | ||||||
Aftermarket
supplies revenue
|
319,857 | 58 | % | 360,765 | 56 | % | 316,975 | 55 | % | |||||||||
Service
revenue
|
73,452 | 13 | % | 74,072 | 12 | % | 65,657 | 12 | % | |||||||||
Revenue
|
$ | 552,814 | 100 | % | $ | 640,017 | 100 | % | $ | 574,798 | 100 | % |
For
the Fiscal Years Ended April 30,
|
||||||||
2009
|
2008
|
2007
|
||||||
Sign
Making and Specialty Graphics
|
58
|
%
|
56
|
%
|
53
|
%
|
||
Apparel
and Flexible Materials
|
32
|
%
|
33
|
%
|
34
|
%
|
||
Ophthalmic
Lens Processing
|
10
|
%
|
11
|
%
|
13
|
%
|
||
100
|
%
|
100
|
%
|
100
|
%
|
For
the Fiscal Years Ended April 30,
|
||||||||||||||||||
In
thousands
|
2009
|
2008
|
2007
|
|||||||||||||||
North
America
|
$
|
215,765
|
39.0
|
%
|
$
|
208,225
|
32.5
|
%
|
$
|
197,451
|
34.4
|
%
|
||||||
Europe
|
248,524
|
45.0
|
%
|
292,252
|
45.7
|
%
|
243,564
|
42.4
|
%
|
|||||||||
Rest
of World
|
88,525
|
16.0
|
%
|
139,540
|
21.8
|
%
|
133,783
|
23.2
|
%
|
|||||||||
Revenue
|
$
|
552,814
|
100.0
|
%
|
$
|
640,017
|
100.0
|
%
|
$
|
574,798
|
100.0
|
%
|
For
the Fiscal Years Ended April 30,
|
||||||||||
In
thousands
|
2009
|
2008
|
2007
|
|||||||
Gross
profit
|
$
|
154,378
|
$
|
186,533
|
$
|
172,374
|
||||
Gross
profit margin
|
27.9
|
%
|
29.1
|
%
|
30.0
|
%
|
For
the Fiscal Years Ended April 30,
|
|||||||||||||||||
In
thousands
|
2009
|
2008
|
Change
|
2008
|
2007 |
Change
|
|||||||||||
Selling,
general and administrative expenses
|
$
|
125,726
|
$
|
135,297
|
(7.1
|
%)
|
|
$
|
135,297
|
$
|
124,460
|
8.7
|
%
|
For
the Fiscal Years Ended April 30,
|
|||||||||||||||||||
In
thousands
|
2009
|
2008
|
Change
|
2008
|
2007
|
Change
|
|||||||||||||
Research
and development expenses ("R&D")
|
$
|
22,417
|
$
|
26,187
|
(14.4
|
%
|
)
|
$
|
26,187
|
$
|
24,282
|
7.8
|
%
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
In
thousands
|
2009
|
2008
|
2007
|
|||||||||
Other
income (expense), net
|
$
|
(4,190
|
)
|
$
|
(132
|
)
|
$
|
524
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
In
thousands
|
2009
|
2008
|
2007
|
|||||||||
Interest
expense
|
$
|
3,746
|
$
|
4,165
|
$
|
3,530
|
||||||
Weighted-average
credit facility interest rates
|
5.7
|
%
|
8.6
|
%
|
9.5
|
%
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Effective
tax rate
|
231.5
|
%
|
30.1
|
%
|
34.5
|
%
|
For
the Fiscal Years Ended April 30,
|
||||||||||||||||||||||||||||||||||||
2009
|
2008
|
2007
|
||||||||||||||||||||||||||||||||||
In
thousands
|
GSP
|
Spandex
|
Total
|
GSP
|
Spandex
|
Total
|
GSP
|
Spandex
|
Total
|
|||||||||||||||||||||||||||
Revenue
|
$
|
89,712
|
$
|
230,993
|
$
|
320,705
|
$
|
102,689
|
$
|
258,397
|
$
|
361,086
|
$
|
89,357
|
$
|
212,730
|
$
|
302,087
|
||||||||||||||||||
Operating
income (loss)
|
$
|
(1,741
|
)
|
$
|
9,559
|
$
|
7,818
|
$
|
1,376
|
$
|
10,592
|
$
|
11,968
|
$
|
5,199
|
$
|
6,419
|
$
|
11,618
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
In
thousands
|
2009
|
2008
|
2007
|
|||||||||
Segment
revenue
|
$
|
174,566
|
$
|
207,945
|
$
|
196,164
|
||||||
Segment
operating profit
|
$
|
12,059
|
$
|
26,681
|
$
|
27,601
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
In
thousands
|
2009
|
2008
|
2007
|
|||||||||
Segment
revenue
|
$
|
57,543
|
$
|
70,986
|
$
|
76,547
|
||||||
Segment
operating profit
|
$
|
3,198
|
$
|
4,384
|
$
|
2,913
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
In
thousands
|
2009
|
2008
|
2007
|
|||||||||
Corporate
operating expenses
|
$
|
16,840
|
$
|
17,984
|
$
|
18,500
|
April
30,
|
||||||||
In
thousands except ratio amounts
|
2009
|
2008
|
||||||
Cash
and cash equivalents
|
$ | 10,313 | $ | 13,892 | ||||
Working
capital
|
$ | 92,839 | $ | 106,005 | ||||
Total
debt
|
$ | 73,500 | $ | 42,000 | ||||
Net
debt (total debt less cash and cash equivalents)
|
$ | 63,187 | $ | 28,108 | ||||
Shareholders'
equity
|
$ | 148,302 | $ | 169,563 | ||||
Total
capital (net debt plus shareholders' equity)
|
$ | 211,489 | $ | 197,671 | ||||
Current
ratio
|
2.02:1
|
1.89:1
|
||||||
Net
debt-to-total capital ratio
|
29.9 | % | 14.2 | % |
For
the Fiscal Years Ended April 30,
|
|||||||||||
In
thousands
|
2009
|
2008
|
2007
|
||||||||
Net
cash provided by operating activities
|
$
|
9,774
|
$
|
10,205
|
$
|
272
|
|||||
Net
cash used for investing activities
|
$
|
(40,418
|
)
|
$
|
(13,764
|
)
|
$
|
(5,901
|
)
|
||
Net
cash provided by financing activities
|
$
|
30,139
|
$
|
7,986
|
$
|
117
|
Total
Funded Debt to Consolidated EBITDA Ratio
|
ABR
Margin
(basis
points)
|
LIBOR
Margin
(basis
points)
|
Commitment
Fee (basis points)
|
|||||||||
3.00x
and greater
|
300.0 | 400.0 | 50.0 | |||||||||
2.25x
to less than 3.00x
|
225.0 | 325.0 | 50.0 | |||||||||
1.50x
to less than 2.25x
|
175.0 | 275.0 | 37.5 | |||||||||
0.75x
to less than 1.50x
|
137.5 | 237.5 | 25.0 | |||||||||
Less
than 0.75x
|
100.0 | 200.0 | 25.0 |
Covenant
|
Requirement
|
Actual
as of April 30, 2009
|
Total
Funded Debt to Consolidated EBITDA
|
Less
than 3.75:1.0
|
3.69:1.0
|
Consolidated
EBIT to Consolidated Interest Expense
|
Greater
than 2.75:1.0
|
3.05:1.0
|
Asset
Coverage Ratio
|
At
least 1.0:1.0
|
1.2:1.0
|
Payments
Due by Period
|
||||||||||||||||||||
In
thousands
|
Total
|
Less
Than
1
Year
|
1-3
Years
|
3-5
Years
|
More
than
5
Years
|
|||||||||||||||
Long-term
debt obligations
|
$
|
73,500
|
*
|
$
|
---
|
$
|
67,500
|
*
|
$
|
---
|
$
|
6,000
|
*
|
|||||||
Lease
obligations
|
59,411
|
11,699
|
17,045
|
12,218
|
18,449
|
|||||||||||||||
Inventory
and other purchase obligations
|
26,728
|
22,901
|
3,827
|
---
|
---
|
|||||||||||||||
Qualified
and non-qualified pension funding
|
5,875
|
586
|
1,163
|
1,163
|
2,963
|
|||||||||||||||
Total
|
$
|
165,514
|
$
|
35,186
|
$
|
89,535
|
$
|
13,381
|
$
|
27,412
|
·
|
proceedings
initiated voluntarily by the director and not by way of defense, except
for claims brought to enforce a right under the indemnification agreement
or claims made with the approval of the Board of Directors;
|
·
|
proceedings
by or in right of Gerber, except for the payment of reasonable expenses
incurred if it is determined that the director met the applicable standard
of conduct under Connecticut law;
|
·
|
proceedings
with respect to conduct for which the director was adjudged liable on the
basis that the director received a financial benefit to which the director
was not entitled;
|
·
|
liability
expressly excluded under Article Seventh, Section 1 of Gerber’s
certificate of incorporation, as it may be amended from time to time;
or
|
·
|
any
claim for expenses or the payment of profits arising out of the director’s
purchase and sale of securities in violation of Section 16(b) of the
Securities Exchange Act of
1934.
|
|
•
|
establishing
a total compensation philosophy and policies that fairly reward Gerber’s
executive officers for performance benefiting shareholders and that
effectively attract and retain the executive resources necessary to manage
Gerber;
|
|
•
|
assessing
the competitiveness of each element of compensation paid to Gerber’s
executive officers;
|
|
•
|
reviewing
and approving the goals and objectives relevant to compensation of the
Chief Executive Officer, or “CEO,” evaluating the performance of the CEO
based on those goals and objectives, and approving the CEO’s compensation
based on this evaluation;
|
|
•
|
reviewing
the CEO’s evaluation of the performance of Gerber’s other executive
officers based on the objectives established and approved by the
Committee, and reviewing and approving the compensation of the other
executive officers, taking into consideration, among other things, the
recommendations of the CEO;
|
|
•
|
administering
Gerber’s equity compensation plans, including approving equity incentive
guidelines, the general size of overall grants, and specific grants to
Gerber’s executive officers and other
employees; and
|
|
•
|
reviewing
succession plans relating to Gerber’s executive officers, including
candidate readiness, management development initiatives and the need for
external talent acquisition.
|
Name(1)
|
Fees
Earned
or
Paid
in
Cash
($)
|
Stock
Awards
($)(2)
|
OptionAwards($)(3)
|
Non-EquityIncentive
PlanCompensation ($)
|
Change
in Pension Value and Nonqualified Deferred Compensation Earnings
($)
|
All
OtherCompensation ($)
|
Total
($)
|
|||||||||||||||||||||
Donald
P. Aiken
|
211,000 | 35,025 | — | — | — | — | 246,025 | |||||||||||||||||||||
Chairman
|
||||||||||||||||||||||||||||
W.
Jerry Vereen
|
80,500 | 35,025 | — | — | — | — | 115,525 | |||||||||||||||||||||
Member
of Audit and Finance Committee, Nominating and Corporate Governance
Committee and Management Development and Compensation
Committee
|
||||||||||||||||||||||||||||
Carole
F. St. Mark
|
76,000 | 35,025 | — | — | — | — | 111,025 | |||||||||||||||||||||
Chair
of Nominating and Corporate Governance Committee and Member of Management
Development and Compensation Committee
|
||||||||||||||||||||||||||||
Edward
G. Jepsen
|
87,250 | 35,025 | — | — | — | — | 122,275 | |||||||||||||||||||||
Chair
of Audit and Finance Committee and Member of Management Development and
Compensation Committee
|
||||||||||||||||||||||||||||
John
R. Lord
|
86,500 | 35,025 | — | — | — | — | 121,525 | |||||||||||||||||||||
Chair
of Management Development and Compensation Committee and Member of Audit
and Finance Committee
|
||||||||||||||||||||||||||||
Randall
D. Ledford
|
68,500 | 35,025 | — | — | — | — | 103,525 | |||||||||||||||||||||
Member
of Nominating and Corporate Governance Committee and Audit and Finance
Committee
|
(1)
|
Mr. Giles
is the only Director who is an employee of Gerber. Mr. Giles does not
receive any compensation for his service on the Board.
|
(2)
|
Amounts
represent the dollar amount recognized for financial statement reporting
purposes for each non-employee Director in fiscal 2009 as computed in
accordance with Statement of Financial Accounting Standards
No. 123(R), Share-Based Payment, or
"SFAS 123R." Because shares issued to the non-employee
Directors are fully vested at grant, the amount shown represents the full
grant date fair value of each annual fee award of $35,025 computed in
accordance with SFAS 123R. For the assumptions relating to this
valuation, see Note 11 of the Notes to Consolidated Financial
Statements in Item 15 of this Annual Report on Form
10-K.
|
(3)
|
As
stated in the narrative preceding the table, all grants of common stock to
the non-employee Directors are fully vested upon grant. Under the 1992
Non-Employee Director Stock Option Plan, which expired in August 2002, the
following Directors continue to hold unexercised stock options, all of
which were fully vested as of April 30,
2009:
|
Director
|
Options (#)
|
|||
Donald
P. Aiken
|
9,000 | |||
W.
Jerry Vereen
|
9,000 | |||
Carole
F. St. Mark
|
9,000 |
§
|
each
executive’s performance;
|
§
|
each
executive’s current total compensation level relative to peer
companies;
|
§
|
Gerber’s
ability to afford the total compensation
package;
|
§
|
the
desire to link pay and performance;
and
|
§
|
the
relative pay among our executives.
|
|
•
|
confirm
Gerber’s historical practice of linking incentive compensation with
results measured at the company and
|
|
business
unit levels;
|
|
•
|
tighten
the existing severance and change in control agreements and thus also
construct a model agreement for future
use; and
|
3D
Systems Corporation
|
ESCO
Technologies, Inc.
|
Newport
Corporation
|
Applied
Materials, Inc.
|
Esterline
Technologies Co.
|
Parametric
Technology Corporation
|
Brooks
Automation, Inc.
|
Excel
Technology, Inc.
|
Rofin-Sinar
Technologies, Inc.
|
Cadence
Design Systems, Inc.
|
GSI
Group, Inc.
|
Roper
Industries, Inc.
|
Coherent,
Inc.
|
KLA-Tencor
Corporation
|
Stratasys,
Inc.
|
Cymer,
Inc.
|
Mentor
Graphics Corporation
|
Tektronix,
Inc.
|
Electroglas,
Inc.
|
MKS
Instruments, Inc.
|
Veeco
Instruments, Inc.
|
|
•
|
individual
performance, which we measure in consultation with Mr. Giles (except
when assessing Mr. Giles’s own
performance);
|
|
•
|
grants
of long-term equity compensation, composed of stock options which vest
over a three-year period and restricted stock which vests over a four-year
period;
|
|
•
|
a
defined benefit retirement pension plan and a 401(k) plan available to all
of our employees, including the named executive officers, on an equal
basis, as well as, for our more highly paid employees (including the named
executive officers), a supplemental employment retirement plan, or
“SERP”; and
|
|
•
|
competitive
severance and change in control agreements for the named executive
officers and some other senior
executives.
|
|
•
|
Mr. Giles,
our CEO, was given a 5.3% base salary increase, from $570,000 to $600,000,
based on the overall strong performance in leading the company,
particularly with regard to placing Gerber on a stronger financial footing
and reinvigorating the new product development process. The Committee
believes that the base salary for Mr. Giles, relative to our other
executive officers, is appropriate given his level of responsibility
within the company and the fact that his base salary is comparable on a
relative basis with CEO base salaries paid by our peer
companies.
|
|
•
|
Mr.
Elia, our CFO, joined the company at the very end of fiscal 2008 and
therefore was not eligible for a salary increase based on fiscal 2008
performance. His salary remained at
$350,000.
|
|
•
|
The
Committee approved a base salary increase of 10.3% for Mr. Hancock,
who took on the additional responsibility of managing the shared Customer
Service organization. Mr. Larson received an increase of 6.3% based on
strong Spandex performance. Mr. Lovass received a 10.9% increase, based on
his transfer to a larger business unit as
President.
|
|
•
|
Mr. Giles,
75% (with a minimum of 0% and a maximum of 150% of base
salary);
|
|
•
|
Mr.
Elia, 60% (with a minimum of 0% and a maximum of 120% of base
salary);
|
|
•
|
Mr. Lovass,
50% (with a minimum of 0% and a maximum of 100% of base
salary);
|
|
•
|
Mr. Hancock,
50% (with a minimum of 0% and a maximum of 100% of base salary);
and
|
|
•
|
Mr. Larson,
50% (with a minimum of 0% and a maximum of 100% of base
salary).
|
|
•
|
his
target payout (expressed as a percentage of base
salary);
|
|
•
|
the
cumulative performance results for fiscal
2009;
|
|
•
|
the
percentage of the executive’s bonus
earned;
|
|
•
|
the
executive’s end-of-year base salary (reflecting the annual salary
increases during fiscal 2009); and
|
|
•
|
the
actual bonus payout.
|
Name
|
Target
%
|
Bonus
%
|
%
Earned
|
Base
$
|
$
Earned
|
|||||||||||||||
Mr.
Giles
|
75 | --- | --- | 600,000 | --- | |||||||||||||||
Mr.
Elia
|
60 | --- | --- | 350,000 | --- | |||||||||||||||
Mr.
Lovass
|
50 | --- | --- | 255,000 | --- | |||||||||||||||
Mr.
Larson
|
50 | --- | --- | 255,000 | --- | |||||||||||||||
Mr.
Hancock
|
50 | --- | --- | 285,000 | --- |
Name
and Principal Position
|
FiscalYear
|
Salary
($)(1)
|
Bonus
($)
|
StockAwards($)(2)
|
Option
Awards
($)(3)
|
Non-EquityIncentive
PlanCompensation ($)(4)
|
Change
inPension Value and Nonqualified Deferred Compensation
Earnings
($)(5)
|
All
OtherCompensation ($)(6)
|
Total
($)
|
||||||||||||||||||||||||
Marc
T. Giles
|
2007
|
528,731 | — | 22,585 | 193,454 | 282,038 | 75,106 | 4,000 | 1,105,914 | ||||||||||||||||||||||||
President
and Chief
|
2008
|
561,346 | — | 86,877 | 328,980 | 288,563 | 72,500 | 4,000 | 1,342,266 | ||||||||||||||||||||||||
Executive
Officer
|
2009
|
544,038 | — | 172,080 | 568,373 | — | 37,600 | — | 1,322,091 | ||||||||||||||||||||||||
Michael
R. Elia
|
2007
|
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Executive
Vice President and Chief
|
2008
|
5,385 | 50,000 | (7) | 7,022 | 17,615 | — | — | 194 | 80,216 | |||||||||||||||||||||||
Financial
Officer
|
2009
|
330,481 | — | 111,175 | 264,000 | — | — | 3,806 | 709,462 | ||||||||||||||||||||||||
Stephen
Lovass.
|
2007
|
203,192 | — | — | 117,750 | 59,450 | 9,343 | 104,725 | 494,460 | ||||||||||||||||||||||||
Senior
Vice President,
|
2008
|
229,999 | — | 20,803 | 67,516 | 81,988 | 8,200 | 64,241 | 472,747 | ||||||||||||||||||||||||
Gerber
Scientific, Inc. and President Gerber Scientific Products
|
2009
|
240,778 | — | 63,909 | 145,044 | — | 4,100 | 109,221 | 563,052 | ||||||||||||||||||||||||
Rodney
Larson
|
2007
|
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Senior
Vice President,
|
2008
|
234,462 | — | 15,580 | 25,926 | 104,050 | — | 207,523 | 587,541 | ||||||||||||||||||||||||
Gerber
Scientific, Inc. and President, Spandex
|
2009
|
235,010 | — | 44,452 | 78,173 | — | — | 263,359 | 639,851 | ||||||||||||||||||||||||
John
Hancock
|
2007
|
241,748 | — | — | 72,634 | 73,402 | 54,006 | 3,095 | 444,885 | ||||||||||||||||||||||||
Senior
Vice President,
|
2008
|
254,897 | 25,834 | (8) | 6,581 | 112,575 | 72,076 | 56,800 | 4,124 | 532,887 | |||||||||||||||||||||||
Gerber
Scientific, Inc. and President, Gerber Technology
|
2009
|
258,850 | — | 90,343 | 106,233 | — | 41,100 | 781 | 497,307 |
(1)
|
Salary
includes compensation used for medical insurance premiums and
contributions to Gerber's 401(k) savings and medical plans, which is not
taxable income.
|
(2)
|
Amounts
represent the dollar amounts recognized for financial statement reporting
purposes during fiscal 2009, fiscal 2008 and fiscal 2007, respectively, as
required by SFAS 123R, disregarding any estimate of forfeitures
relating to service-based vesting conditions.
|
(3)
|
Amounts
represent the dollar amounts recognized for financial statement reporting
purposes for each named executive officer during fiscal 2009, fiscal 2008
and fiscal 2007, respectively, as required by SFAS 123R, disregarding
any estimates of forfeitures relating to service-based vesting conditions.
The weighted-average assumptions used in valuing the amounts set forth
above are as follows:
|
For the Fiscal Years Ended
April 30,
|
||||||||
2009
|
2008
|
2007
|
2006
|
2005
|
||||
Expected
option term
|
5.5
years
|
5.9 years
|
5.0 years
|
5.7 years
|
4.7 years
|
|||
Expected
volatility
|
46%
|
51%
|
55%
|
73%
|
74%
|
|||
Risk-free
interest rate
|
3.0%
|
3.2%
|
4.5%
|
4.4%
|
3.8%
|
|||
(4)
|
Amounts
represent the actual amounts paid to each named executive officer pursuant
to Gerber's fiscal 2009, fiscal 2008 and fiscal 2007 annual incentive
compensation plans, respectively. For fiscal 2009, Gerber did not reach
its performance goals, and paid no bonuses to the named executive
officers. See the “Fiscal 2009 Grants of Plan-Based Awards”
table immediately below and “2009 Annual Incentive Compensation Plan”
under “Compensation Discussion and Analysis–Elements of Our Executive
Compensation Program” above for additional information about our fiscal
2009 annual incentive compensation plan.
|
|||||||
(5)
|
Amounts
represent solely the change in pension value and include both Gerber’s
qualified pension plan and its nonqualified supplemental employee
retirement plan.
|
|||||||
(6)
|
“All
Other Compensation” for fiscal 2009 represents (a) for
Mr. Giles, Gerber’s matching contribution to the company’s 401(k)
plan, which for calendar years 2007 and 2008 was a maximum of $4,000 under
the matching formula which applies to all participants in the 401(k) plan,
and for calendar year 2009 was $0 because the company’s matching
contribution was suspended prior to any contributions to the plan;
(b) for Mr. Elia, Gerber’s matching contribution to the
company’s 401(k) plan; (c) for Mr. Lovass, Gerber’s matching
contribution to the company’s 401(k) plan of $961, foreign tax payments on
his behalf calculated and paid during fiscal 2009 for past assignment in
Belgium of $104,521, tax equalization of $1,240 and foreign tax
preparation service of $2,500; (d) for Mr. Larson, an expatriate
living allowance of $19,027, family tuition fees for the school year of
$124,999, a car lease in the amount of $15,842, foreign tax payments on
his behalf calculated and paid during fiscal 2009 for current assignment
in Belgium of $62,852, tax equalization of $3,939 and foreign tax
preparation service of $2,500, and Gerber’s matching contribution of
$1,009 to the company’s 401(k) plan; and (f) for Mr. Hancock,
the company’s matching contribution to the company’s 401(k)
plan.
|
|||||||
(7)
|
Amount
represents a signing bonus paid to Mr. Elia upon commencement of
employment on April 15, 2008.
|
|||||||
(8)
|
Amount
represents a special incentive bonus for business unit presidents to
reduce inventory during the latter part of fiscal
2008.
|
All
Other
|
All
Other
|
|||||||||||||||||||||||||||||||
Stock
|
Option
|
Grant
Date
|
||||||||||||||||||||||||||||||
Estimated
Possible Payouts Under Non-Equity Incentive Plan
Awards(1)
|
Awards: No.
of
Shares
of
Stock
or
|
Awards: No.
of
Securities
Underlying
|
Exercise
or Base Price of
Option
|
Fair
Value of Stock and Option
|
||||||||||||||||||||||||||||
Grant
|
Threshold
|
Target
|
Maximum
|
Units
|
Options
|
Awards
|
Awards
|
|||||||||||||||||||||||||
Name
|
Date
|
($)
|
($)
|
($)
|
(# | )(2) | (# | )(3) |
($/Sh)
|
($)
|
||||||||||||||||||||||
Marc
T. Giles
|
(1 | ) | — | 450,000 | 900,000 | — | — | — | — | |||||||||||||||||||||||
9/25/08
|
— | — | — | 30,000 | 138,000 | 8.99 | 802,311 | |||||||||||||||||||||||||
Michael
R. Elia
|
(1 | ) | — | 210,000 | 420,000 | — | — | — | — | |||||||||||||||||||||||
9/25/08
|
— | — | — | 15,000 | 45,000 | 8.99 | 308,528 | |||||||||||||||||||||||||
Stephen
Lovass
|
(1 | ) | — | 127,500 | 255,000 | — | — | — | — | |||||||||||||||||||||||
9/25/08
|
— | — | — | 7,500 | 22,500 | 8.99 | 154,264 | |||||||||||||||||||||||||
Rodney
Larson
|
(1 | ) | — | 127,500 | 255,000 | — | — | — | — | |||||||||||||||||||||||
9/25/08
|
— | — | — | 9,400 | 28,200 | 8.99 | 193,344 | |||||||||||||||||||||||||
John
Hancock
|
(1 | ) | — | 142,500 | 285,000 | — | — | — | — | |||||||||||||||||||||||
9/25/08
|
— | — | — | 36,900 | — | 8.99 | 331,731 |
(1)
|
Amounts
represent the potential amounts to be earned under the fiscal 2009 annual
incentive compensation plan. For a discussion of the performance metrics
applicable to these awards, see “2009 Annual Incentive Compensation Plan”
under “Compensation Discussion and Analysis-Elements of Our Executive
Compensation Program” above. For the actual amounts earned by each named
executive officer, see the “Non-Equity Incentive Plan Compensation” column
of the “Fiscal 2009 Summary Compensation Table” above.
|
(2)
|
Represents
awards of restricted stock under the 2006 Omnibus Incentive
Plan. Restricted stock awards generally vest ratably over four
years on each anniversary of the grant date, with the exception of the
grant to Mr. Hancock, which vests ratably over three years on each
anniversary of the grant date
|
(3)
|
Represents
awards of stock options under the 2006 Omnibus Incentive
Plan. Stock option awards vest ratably over three years on each
anniversary of the grant date.
|
Option
Awards
|
Stock
Awards
|
||||||
Number
of
|
Number
of
|
Number
of
|
Market
Value
|
||||
Securities
|
Securities
|
Shares
or
|
of
Shares
|
||||
Underlying
|
Underlying
|
Units
of
|
or
Units of
|
||||
Unexercised
|
Unexercised
|
Option
|
Option
|
Stock
That
|
Stock
That
|
||
Grant
|
Options
(#)
|
Options
(#)
|
Exercise
|
Expiration
|
Have
Not
|
Have
Not
|
|
Name
|
Date
|
Exercisable
|
Unexercisable
|
Price ($)
|
Date
|
Vested (#)
|
Vested
($)(1)
|
Marc
T. Giles
|
12/4/2000(2)
|
50,000
|
—
|
7.06
|
12/4/2010
|
—
|
—
|
President
and Chief
|
12/5/2006(2)
|
33,333
|
16,667
|
13.97
|
12/5/2016
|
8,000
|
31,600
|
Executive Officer |
12/22/2006(3)
|
—
|
41,515
|
12.69
|
12/6/2011
|
—
|
—
|
3/16/2007(4)
|
—
|
33,300
|
9.89
|
6/18/2012
|
—
|
—
|
|
12/1/2007(2)
|
38,333
|
76,667
|
9.50
|
11/30/2017
|
22,500
|
88,875
|
|
9/25/2008(2)
|
—
|
138,000
|
8.99
|
9/25/2018
|
30,000
|
118,500
|
|
Total
|
121,666
|
306,149
|
60,500
|
238,975
|
|||
Michael
R. Elia
|
4/15/2008(5)
|
—
|
100,000
|
8.87
|
4/14/2018
|
20,000
|
79,000
|
Executive
Vice President and Chief Financial Officer
|
9/25/2008(2)
|
—
|
45,000
|
8.99
|
9/25/2018
|
15,000
|
59,250
|
Total
|
—
|
145,000
|
35,000
|
138,250
|
|||
Stephen
Lovass
|
7/1/2004(2)
|
5,000
|
—
|
6.85
|
7/1/2014
|
—
|
—
|
Senior Vice President,
|
12/6/2005(2)
|
15,000
|
—
|
9.45
|
12/6/2015
|
—
|
—
|
Gerber Scientific, Inc., |
12/5/2006(2)
|
10,000
|
5,000
|
13.97
|
12/5/2016
|
—
|
—
|
and President Gerber |
6/19/2007(2)
|
—
|
—
|
—
|
—
|
2,625
|
10,369
|
Scientific Products |
12/1/2007(2)
|
6,667
|
13,333
|
9.50
|
11/30/2017
|
5,250
|
20,737
|
|
3/7/2008(6)
|
—
|
20,000
|
7.91
|
3/7/2018
|
7,000
|
27,650
|
9/25/2008(2)
|
—
|
22,500
|
8.99
|
9/25/2018
|
7,500
|
29,625
|
|
Total
|
36,667
|
60,833
|
22,375
|
88,381
|
|||
Rodney
Larson
|
6/19/2007(2)
|
1,667
|
3,333
|
11.99
|
6/19/2017
|
2,250
|
8,888
|
Senior
Vice
|
12/1/2007(2)
|
8,333
|
16,667
|
9.50
|
11/30/2017
|
6,750
|
26,662
|
President, Gerber Scientific, Inc. and President, Spandex |
9/25/2008(2)
|
—
|
28,200
|
8.99
|
9/25/2018
|
9,400
|
37,130
|
Total
|
|
10,000
|
48,200
|
|
18,400
|
72,680
|
|
John
Hancock
|
5/1/2000(2)
|
6,500
|
—
|
13.62
|
5/1/2010
|
—
|
—
|
Senior
Vice
|
5/4/2001(2)
|
5,525
|
—
|
7.20
|
5/4/2011
|
—
|
—
|
President, Gerber |
12/7/2001(2)
|
20,000
|
—
|
9.34
|
12/7/2011
|
—
|
—
|
Scientific, Inc. and |
6/18/2002(2)
|
20,000
|
—
|
3.35
|
6/18/2012
|
—
|
—
|
President, Gerber |
8/2/2004(2)
|
15,000
|
—
|
6.28
|
8/2/2014
|
—
|
—
|
Technology, Inc. |
12/6/2005(2)
|
20,000
|
—
|
9.45
|
12/6/2015
|
—
|
—
|
12/05/2006(2)
|
13,333
|
6,667
|
13.97
|
12/5/2016
|
—
|
—
|
|
12/1/2007(2)
|
6,667
|
13,333
|
9.50
|
11/30/2017
|
5,250
|
20,738
|
|
9/25/2008(2)
|
—
|
—
|
—
|
—
|
36,900
|
145,755
|
|
Total
|
107,025
|
20,000
|
42,150
|
166,493
|
(1)
|
Valuation
is based on the $3.95 closing price of Gerber’s common stock on
April 30, 2009 as reported on the NYSE.
|
(2)
|
Stock
options granted on these dates generally vest ratably over a three-year
period, beginning on the first anniversary of the grant date. Restricted
stock granted on these dates vest ratably over a four-year period,
beginning on the first anniversary of the grant date, with the exception
of the 9/25/2008 grant to Mr. Hancock, which vests ratably over a
three-year period, beginning on the first anniversary of the grant
date.
|
(3)
|
This
stock option represents a reload stock option granted to Mr. Giles on
December 22, 2006 upon his exercise of the original option. This
option will vest in full on December 22, 2009, assuming
Mr. Giles continues to hold the shares of common stock he received
upon exercise of the original option for the full three-year vesting
requirement.
|
(4)
|
This
stock option represents a reload stock option granted to Mr. Giles on
March 16, 2007 upon his exercise of the original option. This option
will vest in full on March 16, 2010, assuming Mr. Giles
continues to hold the shares of common stock he received upon exercise of
the original option for the full three-year vesting
requirement.
|
(5)
|
Mr. Elia’s
April 25, 2008 stock option and restricted stock grants vest on
April 15, 2010.
|
(6)
|
Mr. Lovass’s
March 7, 2008 stock option and restricted stock grants vest on May 2,
2010.
|
Option
Awards
|
Stock
Awards
|
|||||||||||||||
Name
|
Number of
Shares Acquired on Exercise (#)
|
Value
Realized
on Exercise ($)(1)
|
Number
of SharesAcquired on Vesting (#)
|
Value
Realized
on
Vesting ($)(2)
|
||||||||||||
Marc
T. Giles
|
100,000 | 471,000 | 11,500 | 24,535 | ||||||||||||
Michael
R. Elia
|
— | — | — | — | ||||||||||||
Stephen
Lovass.
|
— | — | 2,625 | 14,131 | ||||||||||||
Rodney
Larson
|
— | — | 3,000 | 13,590 | ||||||||||||
John
Hancock
|
— | — | 1,750 | 3,448 |
(1)
|
Value
realized is calculated by multiplying the number of shares acquired upon
exercise by the difference between the fair market value of Gerber’s
common stock on the date of exercise minus the exercise price of the stock
option.
|
(2)
|
Value
realized is calculated by multiplying the number of shares by the closing
price of Gerber’s common stock on the NYSE on the vesting
date.
|
Fiscal
2009 Pension Benefits Table
|
|||||||||||||
Name
|
Plan
Name
|
Number
of
Years
Credited
Service(1)
|
Present
Value
of
Accumulated
Benefit(2)
|
Payments
During Last Fiscal Year
|
|||||||||
Marc
T. Giles
|
Gerber
Scientific, Inc. and
|
8.5 | |||||||||||
Participating
Subsidiaries Pension Plan
|
$ | 94,200 | — | ||||||||||
Gerber
Scientific, Inc. SERP
|
$ | 210,400 | — | ||||||||||
Stephen
Lovass
|
Gerber
Scientific, Inc. and
|
8.0 | |||||||||||
Participating
Subsidiaries Pension Plan
|
$ | 33,100 | — | ||||||||||
Gerber
Scientific, Inc. SERP
|
$ | 6,400 | — | ||||||||||
John
Hancock
|
Gerber
Scientific, Inc. and
|
11.2 | |||||||||||
Participating
Subsidiaries Pension Plan
|
$ | 225,400 | — | ||||||||||
Gerber
Scientific, Inc. SERP
|
$ | 83,800 | — |
(1)
|
Number
of years of credited service is computed as of April 30, 2009. The
number of years of credited service for each named executive officer is
equal to his actual years of service with Gerber as of April 30,
2009. Gerber does not have a policy of granting extra years of credited
service to its named executive officers or other participating employees
generally.
|
(2)
|
Amounts
represent the present value of the accumulated benefit under the qualified
plan or SERP, as applicable, as of April 30, 2009. For the
assumptions used in determining these amounts, see Note 13 of the
Notes to Consolidated Financial Statements in Item 15 of this Annual
Report on Form 10-K.
|
|
•
|
continuation
of base salary, as in effect as of the termination date, for
(1) 16 months, in the case of Mr. Giles, or
(2) 12 months, in the case of Messrs. Elia, Lovass, Larson
and Hancock, payable in accordance with the company’s normal payroll
practices;
|
|
•
|
the
pro rata portion (through the date of termination) of the target annual
incentive compensation that the officer would have earned if the officer
had continued his employment with the company through the end of the
fiscal year in which the termination occurred, payable at the time such
compensation is normally paid and only if the performance goals relating
to the compensation are
achieved; and
|
|
•
|
continuation
of company-paid health (medical and dental) insurance coverage for
(1) 16 months, in the case of Mr. Giles, or
(2) 12 months, in the case of Messrs. Elia, Lovass, Larson
and Hancock, and continued life insurance benefits for a period of
30 days following
termination.
|
|
•
|
competes
with the business of the company;
|
|
•
|
discloses
confidential information or data relating to the
company;
|
|
•
|
appropriates
any such information or data for his own
benefit;
|
|
•
|
solicits
or hires any person who is, or has been in the prior six months, employed
by the company to leave the
company;
|
|
•
|
solicits
or diverts the business of any customer or client, or any prospective
customer or client, of the company;
|
|
•
|
engages
in any action that is determined by the Management Development and
Compensation Committee to be detrimental to the company and its
shareholders; or
|
|
•
|
is
engaged in full-time employment, other than as described above regarding
employment with a company that is not a competitor of the
company.
|
|
•
|
a
lump sum severance payment equal to (1) three times the sum of his
base salary and annual incentive bonus payment in effect as of the
termination date, in the case of Mr. Giles, or (2) 2.5 times the
sum of his base salary and annual incentive bonus payment in effect as of
the termination date, in the case of each of Messrs. Elia, Lovass,
Larson and Hancock;
|
|
•
|
a
lump sum cash payment equal to (1) 36 monthly payments, in the
case of Mr. Giles, or (2) 30 monthly payments, in the case
of each of Messrs. Elia, Lovass, Larson and Hancock, that would have
been paid by the company for the cost of all life insurance, health
(medical and dental), accidental death and dismemberment, and disability
plans in which the executive was entitled to participate immediately prior
to the date of
termination; and
|
|
•
|
acceleration
and full vesting of all unvested stock
awards.
|
|
•
|
a
material diminution in the nature and scope of the executive’s authority,
duties or responsibilities from those applicable immediately prior to the
change in control;
|
|
•
|
a
reduction in the executive’s base salary from that provided immediately
prior to the change in control;
|
|
•
|
a
diminution in the executive’s eligibility to participate in compensation
plans and employee benefits and perquisites which provided opportunities
to receive overall compensation and benefits and perquisites from the
greater of:
|
|
•
|
the
opportunities provided by the company for executives with comparable
duties; or
|
|
•
|
the
opportunities under any such plans and perquisites under which the
executive was participating immediately prior to the change in
control.
|
|
•
|
a
change in the location of the executive’s principal place of employment by
more than 50 miles from the location applicable immediately prior to
the change in control;
|
|
•
|
a
significant increase in the executive’s frequency or duration of business
travel; or
|
|
•
|
a
reasonable determination by the Board of Directors that, as a result of
the change in control and change in circumstances thereafter significantly
affecting the executive’s position, the executive is unable to exercise
the authority, powers, functions or duties applicable to his position
immediately prior to the change in
control.
|
|
•
|
the
company merges or consolidates with another entity resulting in less than
50% ownership, or the company sells or otherwise disposes of all or
substantially all of its assets;
|
|
•
|
the
shareholders of the company adopt a plan of
liquidation;
|
|
•
|
any
person generally becomes the beneficial owner of 30% or more of the
company’s voting securities; or
|
|
•
|
as
a result of any tender or exchange offer, merger or disposition of all or
substantially all of the company’s assets, the Directors of the company as
of the date of the severance agreements cease to constitute a majority of
the Board of Directors (with exception for Directors subsequently approved
by three-fourths of the Directors as of the date of the severance
agreements).
|
|
•
|
the
entry by the company into an agreement, the consummation of which would
result in the occurrence of a change in
control;
|
|
•
|
the
public announcement by any person of an intention to take actions which,
if consummated, would constitute a change in
control; or
|
|
•
|
the
adoption by the Board of Directors of a resolution to the effect that, for
purposes of the severance agreements, a change in control has
occurred.
|
Named
Executive Officer
|
Severance
Policy($)(1)
|
Change
in Control
Agreements($)(2)
|
Continuation
of Vesting
Upon
Retirement($)(3)
|
|||||||||
Marc
T. Giles
|
815,380 | 2,527,639 | — | |||||||||
Michael
R. Elia
|
360,625 | 1,252,722 | — | |||||||||
Stephen
Lovass.
|
266,492 | 884,321 | — | |||||||||
Rodney
Larson
|
266,492 | 868,620 | — | |||||||||
John
Hancock
|
296,499 | 1,031,932 | — |
(1)
|
Amounts
calculated based on each executive’s base salary as of April 30,
2009, or $800,000 ($600,000 times 1.33 years) for Mr. Giles, $350,000
for Mr. Elia, $255,000 for Mr. Lovass, $255,000 for Mr. Larson
and $285,000 for Mr. Hancock. Amounts include continuation of health
(medical and dental) and life insurance benefits for the periods described
under “Severance Policy for Senior Executives” above as follows: $15,380
for Mr. Giles; $10,650 for Mr. Elia; $11,492 for
Mr. Lovass; $11,492 for Mr. Larson; and $11,499 for
Mr. Hancock. Amounts do not include any pro rata bonus payments; each
executive’s fiscal 2009 bonus is set forth in the fiscal 2009 “Non-Equity
Incentive Compensation Plan” column of the “Fiscal 2009 Summary
Compensation Table” above.
|
(2)
|
Represents
amounts to be provided pursuant to each executive’s change in control
agreement. Amounts include the following: (a) a lump sum severance
payment, calculated based on each executive’s base salary as of
April 30, 2009, or $1,800,000 ($600,000 times three years) for
Mr. Giles, $875,000 ($350,000 times 2.5 years) for
Mr. Elia, $637,500 ($255,000 times 2.5 years) for
Mr. Lovass, $637,500 ($255,000 times 2.5 years) for
Mr. Larson and $712,500 ($285,000 times 2.5 years) for
Mr. Hancock, and each executive’s target annual incentive bonus
payment for fiscal 2009, or $450,000 for Mr. Giles, $210,00 for Mr.
Elia, $127,500 for Mr. Lovass, $127,500 for Mr. Larson and
$142,500 for Mr. Hancock; (b) a lump sum payment equal to
$38,664 for Mr. Giles, $29,472 for Mr. Elia, $30,940 for
Mr. Lovass, $30,940 for Mr. Larson and $31,177 for
Mr. Hancock, reflecting the amount the company would have paid for
the cost of all life insurance, health (medical and dental), accidental
death and dismemberment and disability plans in which the executive was
entitled to participate as of April 30, 2009; and (c) the
acceleration of all unvested stock option and restricted stock awards held
by each officer as of April 30, 2009, as follows: $238,975 for
Mr. Giles, $138,250 for Mr. Elia, $88,381 for Mr. Lovass,
$72,680 for Mr. Larson and $145,755 for Mr. Hancock. For stock
option awards, amounts calculated are based on the difference between the
option’s exercise price and the fair market value of our common stock on
April 30, 2009, or $3.95 per share, multiplied by the number of
shares. For restricted stock awards, the amount calculated is based on the
number of shares multiplied by the fair market value of our common stock
on April 30, 2009. For purposes of these equity acceleration
estimates, we have not included outstanding unvested out-of-the-money
stock option awards pursuant to which the exercise price of the option
exceeded the fair market value of our common stock on April 30, 2009.
See the “Fiscal 2009 Outstanding Equity Awards at Fiscal Year-End” table
above for information on these awards.
|
(3)
|
As
discussed above, executives holding outstanding, unvested stock option
awards under our 2003 Employee Stock Option Plan are entitled to two
additional years of vesting upon retirement. As of April 30, 2009,
however, unvested stock options outstanding under this plan were
out-of-the-money options because the exercise price of the options
exceeded the fair market value of our common stock on April 30, 2009,
or $3.95 per share.
|
Name
and Address of Beneficial Owner
|
Amount
and Nature of
Beneficial
Ownership
|
Percent
of
Class (%)
|
||||||
Mario
J. Gabelli and affiliates
|
2,247,263 | 9.13 | ||||||
One
Corporate Center
|
||||||||
Rye,
New York 10580
|
||||||||
Zesiger
Capital Group LLC
|
2,051,400 | 8.33 | ||||||
320
Park Ave. 30th Floor,
|
||||||||
New
York, New York 10022
|
||||||||
Barclays
Global Investors, NA
|
1,851,697 | 7.52 | ||||||
45
Fremont Street
|
||||||||
San Francisco,
California 94105
|
||||||||
Dimensional
Fund Advisors LP
|
1,685,698 | 6.85 | ||||||
1299
Ocean Avenue
|
||||||||
Santa
Monica, California 90401
|
||||||||
FMR
LLC
|
1,450,300 | 5.89 | ||||||
82
Devonshire Street
|
||||||||
Boston,
Massachusetts 02109
|
||||||||
Royce &
Associates, LLC
|
1,360,583 | 5.53 | ||||||
1414
Avenue of the Americas
|
||||||||
New
York, New York 10019
|
|
•
|
each
Director;
|
|
•
|
the
“named executive officers” of Gerber as set forth in the Fiscal 2009
Summary Compensation Table
above; and
|
|
•
|
all
of Gerber's Directors and executive officers as a
group.
|
Name
of Beneficial Owner
|
Amount
and Nature of
Beneficial
Ownership
|
Percent
of
Class (%)
|
||||||
Donald
P. Aiken
|
61,859 | * | ||||||
Michael
R. Elia
|
54,841 | * | ||||||
Marc
T. Giles
|
290,227 | 1.17 | ||||||
John
Hancock
|
152,763 | * | ||||||
Edward
G. Jepsen
|
316,283 | 1.29 | ||||||
Rodney
Larson
|
34,830 | * | ||||||
Stephen
P. Lovass
|
61,391 | * | ||||||
Randall
D. Ledford
|
22,914 | * | ||||||
John
R. Lord
|
37,914 | * | ||||||
Carole
F. St. Mark
|
47,687 | * | ||||||
W.
Jerry Vereen
|
51,428 | * | ||||||
All
Directors and executive officers as a group
(17 persons)
|
1,465,933 | 5.83 |
*
|
Less
than one percent.
|
Plan
Category
|
Number
of securities
to
be issued upon the
exercise
of outstanding
options,
warrants and
rights
(#) (a)
|
Weighted-average
exercise
price of
outstanding
options,
warrants
and
rights($)
(b)
|
Number
of securities
remaining
available
for
future issuance
under
equity
compensation
plans
(excluding
securities
in
column(a)) (#)
(c)
|
|||||||||
Equity
compensation plans approved by shareholders
|
2,187,746 | (1) | 9.81 | 922,507 | (2) |
(1)
|
Excludes
1,809 shares of restricted stock outstanding under the Gerber
Scientific, Inc. 2003 Employee Stock Option Plan and 976,350 shares
of restricted stock outstanding under the Gerber Scientific, Inc. 2006
Omnibus Incentive Plan as of April 30, 2009.
|
(2)
|
Represents
922,507 shares of common stock remaining available for issuance
pursuant to awards under the Gerber Scientific, Inc. 2006 Omnibus
Incentive Plan. Up to 922,507 of the shares of common stock remaining
available for issuance pursuant to awards under this plan may be issued
pursuant to awards other than upon the exercise of an option, warrant or
right.
|
2009
|
2008
|
|||||||
Audit
services
|
$ | 2,251,455 | $ | 3,161,120 | ||||
Audit-related
services
|
--- | 219,154 | ||||||
Tax
services
|
185,913 | 265,008 | ||||||
All
other services
|
7,500 | 6,060 | ||||||
Total
|
$ | 2,444,868 | $ | 3,651,342 |
Page
|
||||
80
|
||||
1.
|
Financial
Statements:
|
|||
81
|
||||
82
|
||||
83
|
||||
84
|
||||
85
|
||||
86-112
|
||||
2.
|
Financial
Statement Schedules
|
|||
All
financial statement schedules are omitted because they are not applicable
or the required information is shown in the consolidated financial
statements or notes thereto.
|
||||
3.
|
Exhibits
Gerber
Scientific, Inc. herewith files or incorporates herein the following
exhibits:
|
Exhibit
Number
|
Exhibit
Description
|
|||
2.1
|
Support
Agreement among Gerber Scientific Canada Inc., Gerber Scientific, Inc.
("Gerber") and Virtek Vision International, Inc., effective September 4,
2008 (incorporated herein by reference to Exhibit 2.1 to Gerber's Current
Report on Form 8-K filed on September 10, 2008).
|
|||
3.1
|
Amended
and Restated Certificate of Incorporation of Gerber Scientific, Inc.
(incorporated herein by reference to Exhibit 3.1 to Gerber's Quarterly
Report on Form 10-Q for the fiscal quarter ended October 31,
2004).
|
|||
3.2
|
Amended
and Restated By-laws of Gerber Scientific, Inc. (incorporated herein by
reference to Exhibit 3.2 to Gerber's Current Report on Form 8-K filed on
May 1, 2007).
|
|||
4.1
|
Form
of common stock certificate of Gerber Scientific, Inc. (incorporated
herein by reference to Exhibit 4.1 to Gerber's Annual Report on Form 10-K
for the fiscal year ended April 30, 2007).
|
|||
10.1
|
Gerber
Scientific, Inc. Non-Employee Director's Stock Grant Plan, as amended and
restated (incorporated herein by reference to Exhibit 10.1 to Gerber's
Quarterly Report on Form 10-Q for the fiscal quarter ended October 31,
2006).
|
|||
10.2
|
Gerber
Scientific, Inc. 1992 Non-Employee Director Stock Option Plan, as amended
and restated (incorporated herein by reference to Exhibit 10.2 to Gerber's
Annual Report on Form 10-K for the fiscal year ended April 30,
1999).
|
|||
10.3
|
Gerber
Scientific, Inc. Agreement for Deferment of Director Fees, as amended
(incorporated herein by reference to Exhibit 10.1 to Gerber's Current
Report on Form 8-K filed on December 2, 2005).
|
|||
10.4
|
Gerber
Scientific, Inc. 2006 Omnibus Incentive Plan, as amended (incorporated
herein by reference to Exhibit 10.1 to Gerber's Form 8-K filed on
September 25, 2008).
|
|||
10.5
|
Letter
Agreement, dated as of December 7, 2001, between Gerber Scientific, Inc.
and Marc T. Giles (incorporated herein by reference to Exhibit 10.6 to
Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended
January 31, 2002).
|
|||
10.6
|
Letter
Agreement, dated as of March 14, 2008, between Gerber Scientific, Inc. and
Michael R. Elia (incorporated herein by reference to Exhibit 10.6 to
Gerber's Annual Report on Form 10-K for the fiscal year ended April 30,
2008).
|
10.7
|
Form
of Restricted Stock Agreement under the Gerber Scientific, Inc. 2006
Omnibus Incentive Plan (incorporated herein by reference to Exhibit 99.1
to Gerber's Current Report on Form 8-K filed on November 9,
2006).
|
10.8
|
Form
of Nonqualified Stock Option Agreement under the Gerber Scientific, Inc.
2006 Omnibus Incentive Plan (incorporated herein by reference to Exhibit
99.2 to Gerber's Current Report on Form 8-K filed on November 9,
2006).
|
10.9
|
Letter
Agreement, dated as of September 30, 2002, between Gerber Scientific, Inc.
and James S. Arthurs (incorporated herein by reference to Exhibit 10.15 of
Gerber's Annual Report on Form 10-K for the fiscal year ended April 30,
2003).
|
10.10
|
Letter
Agreement, dated as of December 7, 2001, between Gerber Scientific, Inc.
and John R. Hancock (incorporated herein by reference to Exhibit 10.8 to
Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended
January 31, 2002).
|
10.11
|
Form
of Change in Control Agreement, dated July 14, 1999, between Gerber
Scientific, Inc. and its Senior Vice Presidents, including Marc T. Giles
(incorporated herein by reference to Exhibit 10.2 to Gerber's Quarterly
Report on Form 10-Q for the fiscal quarter ended July 31,
1999).
|
10.12
|
Severance
Policy for Senior Officers of Gerber Scientific, Inc. as Amended and
Restated Effective September 21, 2006 (incorporated herein by reference to
Exhibit 10.12 to Gerber's Annual Report on Form 10-K for the fiscal year
ended April 30, 2007).
|
10.13
|
Agreement
and Lease between Spandex PLC and IM Properties Finance Limited for the
sale and leaseback of property in Bristol, United Kingdom (incorporated
herein by reference to Exhibit 10.3 to Gerber's Quarterly Report on Form
10-Q for the fiscal quarter ended January 31, 2001).
|
10.14
|
Lease
Agreement between GERB (CT) QRS 14-73, Inc. and Gerber Scientific, Inc.,
Gerber Technology, Inc., Gerber Scientific Products, Inc., and Gerber
Coburn Optical, Inc. (incorporated herein by reference to Exhibit 10.1 to
Gerber's Quarterly Report on Form 10-Q for the fiscal quarter ended July
31, 2001).
|
10.15
|
Gerber
Scientific, Inc. and Participating Subsidiaries Supplemental Pension
Benefit Plan (incorporated herein by reference to Exhibit 10.5 to Gerber's
Annual Report on Form 10-K for the fiscal year ended April 30,
1999).
|
First
Amendment to the Gerber Scientific, Inc. and Participating Subsidiaries
Supplemental Pension Benefit Plan. Filed
herewith.
|
|
10.17
|
Gerber
Scientific, Inc. 1992 Employee Stock Plan, as amended and restated
(incorporated herein by reference to Exhibit A to Gerber's Proxy Statement
on Schedule 14A filed on August 28, 1995).
|
10.18
|
Gerber
Scientific, Inc. 2003 Employee Stock Option Plan, as amended and restated
(incorporated herein by reference to Exhibit 10.17 to Gerber's Annual
Report on Form 10-K for the fiscal year ended April 30,
2007).
|
10.19
|
Gerber
Scientific, Inc. 2005-2006 Executive Annual Incentive Bonus Plan
(incorporated herein by reference to Exhibit 4.3 to Gerber's Registration
Statement on Form S-8, File No. 333-116991).
|
10.20
|
Letter
Agreement, dated as of October 1, 2004, between Gerber Scientific, Inc.
and William V. Grickis, Jr. (incorporated herein by reference to Exhibit
10.3 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter
ended October 31, 2004).
|
10.21
|
Letter
Agreement, dated as of December 18, 2003, between Gerber Scientific, Inc.
and Donald P. Aiken (incorporated herein by reference to Exhibit 10.33 to
Gerber's Annual Report on Form 10-K for the fiscal year ended April 30,
2004).
|
10.22
|
Form
of Nonqualified Stock Option Agreement pursuant to the Gerber Scientific,
Inc. 2003 Employee Stock Option Plan (incorporated herein by reference to
Exhibit 10.1 to Gerber's Quarterly Report on Form 10-Q for the fiscal
quarter ended October 31,
2004).
|
10.23
|
Form
of Restricted Stock Agreement pursuant to the Gerber Scientific, Inc. 2003
Employee Stock Option Plan (incorporated herein by reference to Exhibit
10.2 to Gerber's Quarterly Report on Form 10-Q for the fiscal quarter
ended October 31, 2004).
|
10.24
|
Change
in Control Agreement, dated October 1, 2005, between Gerber Scientific,
Inc. and William V. Grickis, Jr. (incorporated herein by reference to
Exhibit 10.3 to Gerber's Quarterly Report on Form 10-Q for the fiscal
quarter ended October 31, 2004).
|
10.25
|
Change
in Control Agreement, dated April 15, 2008, between Gerber Scientific,
Inc. and Michael R. Elia (incorporated herein by reference to Exhibit
10.24 to Gerber's Annual Report on Form 10-K for the fiscal year ended
April 30, 2008).
|
10.26
|
Credit
Agreement, dated as of January 31, 2008, among Gerber Scientific, Inc.,
certain subsidiaries of Gerber Scientific, Inc., JP Morgan Chase Bank
N.A., HSBC Bank USA, National Association, Merrill Lynch Capital
Corporation, Bank of America, N.A., Sovereign Bank as documentation agent,
Citizens Bank of Massachusetts as administrative agent, and RBS Greenwich
Capital as sole lead arranger (incorporated herein by reference to Exhibit
10.1 to Gerber's Current Report on Form 8-K filed on February 6,
2008).
|
10.27
|
First
Amendment to Credit Agreement, dated as of November 21, 2008, among Gerber
Scientific, Inc., certain subsidiaries of Gerber Scientific, Inc., JP
Morgan Chase Bank N.A., HSBC Bank USA, National Association, Merrill Lynch
Capital Corporation, Bank of America, N.A., Sovereign Bank, and RBS
Citizens N.A. as lender and agent (incorporated herein by reference to
Exhibit 10.2 to Gerber's Quarterly Report on Form 10-Q for the fiscal
quarter ended October 31, 2008).
|
Second
Amendment to Credit Agreement, dated as of March 4, 2009, among Gerber
Scientific, Inc., certain subsidiaries of Gerber Scientific, Inc., JP
Morgan Chase Bank N.A., HSBC Bank USA, National Association, Merrill Lynch
Capital Corporation, Bank of America, N.A., Sovereign Bank, and RBS
Citizens N.A. as lender and agent. Filed
herewith.
|
|
10.29
|
Letter
Agreement, dated as of November 3, 2007, between Gerber Scientific, Inc.
and Joseph R. Mele (incorporated herein by reference to Exhibit 10.26 to
Gerber's Annual Report on Form 10-K for the fiscal year ended April 30,
2008).
|
10.30
|
Change
in Control Agreement, dated March 4, 2008, between Gerber Scientific, Inc.
and Joseph R. Mele (incorporated herein by reference to Exhibit 10.27 to
Gerber's Annual Report on Form 10-K for the fiscal year ended April 30,
2008).
|
Subsidiaries
of Gerber. Filed herewith.
|
|
Consent
of PricewaterhouseCoopers LLP, Independent Registered Public Accounting
Firm. Filed herewith.
|
|
Certification
of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)
under the Securities Exchange Act of 1934. Filed
herewith.
|
|
Certification
of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)
under the Securities Exchange Act of 1934. Filed
herewith.
|
|
Certification
of Chief Executive Officer and Chief Financial Officer pursuant Rule
13a-14(b) or Rule 15d-14(b) and to 18 U.S.C. §1350. Filed
herewith.
|
|
(b)
|
See
Item 15(a) 3. above.
|
(c)
|
See
Item 15(a) 2. above.
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
In
thousands of dollars, except per share data
|
2009
|
2008
|
2007
|
|||||||||
Revenue:
|
||||||||||||
Product
sales
|
$
|
479,362
|
$
|
565,945
|
$
|
509,141
|
||||||
Service
sales
|
73,452
|
74,072
|
65,657
|
|||||||||
552,814
|
640,017
|
574,798
|
||||||||||
Cost
of Sales:
|
||||||||||||
Cost
of products sold
|
350,722
|
403,776
|
362,215
|
|||||||||
Cost
of services sold
|
47,714
|
49,708
|
40,209
|
|||||||||
398,436
|
453,484
|
402,424
|
||||||||||
Gross
profit
|
154,378
|
186,533
|
172,374
|
|||||||||
Selling,
general and administrative expenses
|
125,726
|
135,297
|
124,460
|
|||||||||
Research
and development
|
22,417
|
26,187
|
24,282
|
|||||||||
Operating
income
|
6,235
|
25,049
|
23,632
|
|||||||||
Other
income (expense), net
|
(4,190
|
)
|
(132
|
)
|
524
|
|||||||
Interest
expense
|
(3,746
|
)
|
(4,165
|
)
|
(3,530
|
)
|
||||||
(Loss)
Income before income taxes
|
(1,701
|
)
|
20,752
|
20,626
|
||||||||
Income
tax (benefit) expense
|
(3,937
|
)
|
6,248
|
7,118
|
||||||||
Net
income
|
$
|
2,236
|
$
|
14,504
|
$
|
13,508
|
||||||
Earnings
Per Share of Common Stock:
|
||||||||||||
Basic
|
$
|
0.09
|
$
|
0.62
|
$
|
0.59
|
||||||
Diluted
|
$
|
0.09
|
$
|
0.61
|
$
|
0.58
|
April
30,
|
||||||||
In
thousands of dollars and shares
|
2009
|
2008
|
||||||
Assets:
|
||||||||
Current
Assets:
|
||||||||
Cash
and cash equivalents
|
$
|
10,313
|
$
|
13,892
|
||||
Accounts
receivable (net of allowance for doubtful accounts of $6,741 and
$6,384)
|
87,798
|
120,752
|
||||||
Inventories
|
72,108
|
76,927
|
||||||
Deferred
tax assets, net
|
9,022
|
7,600
|
||||||
Prepaid
expenses and other current assets
|
4,659
|
5,829
|
||||||
Total
Current Assets
|
183,900
|
225,000
|
||||||
Property,
plant and equipment, net
|
37,119
|
39,852
|
||||||
Goodwill
|
76,940
|
61,844
|
||||||
Deferred
tax assets, net
|
43,339
|
34,354
|
||||||
Other
assets
|
17,919
|
17,489
|
||||||
Total
Assets
|
$
|
359,217
|
$
|
378,539
|
||||
Liabilities
and Shareholders' Equity:
|
||||||||
Current
Liabilities:
|
||||||||
Accounts
payable
|
$
|
37,494
|
$
|
51,253
|
||||
Accrued
compensation and benefits
|
15,735
|
23,671
|
||||||
Other
accrued liabilities
|
24,748
|
27,672
|
||||||
Deferred
revenue
|
13,084
|
16,399
|
||||||
Total
Current Liabilities
|
91,061
|
118,995
|
||||||
Long-term
debt
|
73,500
|
42,000
|
||||||
Accrued
pension benefit liability
|
29,629
|
28,514
|
||||||
Other
long-term liabilities
|
16,725
|
19,467
|
||||||
Commitments
and contingencies (Note 18)
|
||||||||
Shareholders'
Equity:
|
||||||||
Preferred
stock, $0.01 par value; authorized 10,000 shares; no shares
issued
|
---
|
---
|
||||||
Common
stock, $0.01 par value; authorized 100,000 shares; issued 25,174
and 24,300 shares
|
252
|
243
|
||||||
Paid-in
capital
|
79,198
|
75,472
|
||||||
Retained
earnings
|
97,662
|
95,426
|
||||||
Treasury
stock, 561 and 591 shares, at cost
|
(11,531
|
)
|
(12,148
|
)
|
||||
Accumulated
other comprehensive (loss) income
|
(17,279
|
)
|
10,570
|
|||||
Total
Shareholders' Equity
|
148,302
|
169,563
|
||||||
Total
Liabilities and Shareholders' Equity
|
$
|
359,217
|
$
|
378,539
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
In
thousands of dollars
|
2009
|
2008
|
2007
|
|||||||||
Cash
flows from operating activities:
|
||||||||||||
Net
income
|
$
|
2,236
|
$
|
14,504
|
$
|
13,508
|
||||||
Adjustments
to reconcile net income to cash provided by operating
activities:
|
||||||||||||
Depreciation
and amortization
|
9,991
|
9,518
|
8,756
|
|||||||||
Deferred
income taxes
|
(5,953
|
)
|
2,501
|
1,609
|
||||||||
Other-than-temporary
impairment charge
|
2,290
|
---
|
---
|
|||||||||
Stock-based
compensation
|
3,241
|
1,805
|
1,751
|
|||||||||
Gain
on sale of assets
|
(622
|
)
|
(2,287
|
)
|
---
|
|||||||
Other
noncash items
|
2,220
|
2,191
|
1,293
|
|||||||||
Changes
in operating accounts, excluding effects of acquisitions:
|
||||||||||||
Accounts
receivable
|
25,795
|
(5,719
|
)
|
(11,618
|
)
|
|||||||
Inventories
|
5,820
|
(6,220
|
)
|
(9,624
|
)
|
|||||||
Prepaid
expenses and other assets
|
79
|
696
|
(1,154
|
)
|
||||||||
Accounts
payable and other accrued liabilities
|
(27,424
|
)
|
(7,095
|
)
|
(3,221
|
)
|
||||||
Accrued
compensation and benefits
|
(7,899
|
)
|
311
|
(1,028
|
)
|
|||||||
Net
cash provided by operating activities
|
9,774
|
10,205
|
272
|
|||||||||
Cash
flows from investing activities:
|
||||||||||||
Capital
expenditures
|
(8,187
|
)
|
(8,589
|
)
|
(3,945
|
)
|
||||||
Proceeds
from sale of available for sale investments
|
705
|
751
|
6,216
|
|||||||||
Purchases
of available for sale investments
|
(457
|
)
|
(753
|
)
|
(6,037
|
)
|
||||||
Proceeds
from sale of assets
|
2,622
|
345
|
---
|
|||||||||
Business
acquisitions
|
(34,273
|
)
|
(4,650
|
)
|
(1,510
|
)
|
||||||
Intangible
assets expenditures
|
(828
|
)
|
(868
|
)
|
(625
|
)
|
||||||
Net
cash used for investing activities
|
(40,418
|
)
|
(13,764
|
)
|
(5,901
|
)
|
||||||
Cash
flows from financing activities:
|
||||||||||||
Debt
repayments
|
(80,271
|
)
|
(314,256
|
)
|
(301,560
|
)
|
||||||
Debt
proceeds
|
110,686
|
321,862
|
297,756
|
|||||||||
Debt
issuance costs
|
(1,174
|
)
|
(993
|
)
|
---
|
|||||||
Common
stock issued
|
898
|
1,373
|
3,921
|
|||||||||
Net
cash provided by financing activities
|
30,139
|
7,986
|
117
|
|||||||||
Effect
of exchange rate changes on cash
|
(3,074
|
)
|
1,413
|
(581
|
)
|
|||||||
(Decrease) Increase
in cash and cash equivalents
|
(3,579
|
)
|
5,840
|
(6,093
|
)
|
|||||||
Cash
and cash equivalents at beginning of year
|
13,892
|
8,052
|
14,145
|
|||||||||
Cash
and cash equivalents at end of year
|
$
|
10,313
|
$
|
13,892
|
$
|
8,052
|
||||||
Supplemental
Schedule of Cash Flow Information
|
||||||||||||
Cash
paid during the year for:
|
||||||||||||
Interest
|
$
|
2,856
|
$
|
3,655
|
$
|
3,232
|
||||||
Income
taxes, net of refunds
|
$
|
4,456
|
$
|
5,290
|
$
|
3,333
|
In
thousands of dollars and shares
|
Issued
Common
Stock
Shares
|
Common
Stock
|
Paid-in
Capital
|
Retained
Earnings
|
Treasury
Stock
|
Unamort.
Value
of
Restrict.
Stock
Grants
|
Accum.
Other
Comp.
Income
(Loss)
|
Total
|
||||||||||||||||||||||
Balance
as of April 30, 2006
|
23,265
|
$
|
233
|
$
|
67,339
|
$
|
69,782
|
$
|
(13,496
|
)
|
$
|
(136
|
)
|
$
|
1,894
|
$
|
125,616
|
|||||||||||||
Net
income
|
--
|
--
|
--
|
13,508
|
--
|
--
|
--
|
13,508
|
||||||||||||||||||||||
Currency
translation adjustments
|
--
|
--
|
--
|
--
|
--
|
--
|
7,266
|
7,266
|
||||||||||||||||||||||
Unrealized
loss on securities, net of reclassification adjustment of
$(989)
and
tax of $(273)
|
--
|
--
|
--
|
--
|
--
|
--
|
(462
|
)
|
(462
|
)
|
||||||||||||||||||||
Minimum
pension liability change, net
of
tax of $(863)
|
--
|
--
|
--
|
--
|
--
|
--
|
1,384
|
1,384
|
||||||||||||||||||||||
Comprehensive
income
|
21,696
|
|||||||||||||||||||||||||||||
Initial
application of SFAS 158, net of
tax
of $5,300
|
--
|
--
|
--
|
--
|
--
|
--
|
(8,927
|
)
|
(8,927
|
)
|
||||||||||||||||||||
Cumulative
effect of adoption of SFAS 123(R)
|
--
|
--
|
(136
|
)
|
--
|
--
|
136
|
--
|
--
|
|||||||||||||||||||||
Stock
issued to Directors
|
--
|
--
|
(258
|
)
|
--
|
682
|
--
|
--
|
424
|
|||||||||||||||||||||
Stock
issued under employee plans, net
|
513
|
5
|
3,978
|
--
|
--
|
--
|
--
|
3,983
|
||||||||||||||||||||||
Stock
based compensation expense
|
--
|
--
|
1,581
|
--
|
--
|
--
|
--
|
1,581
|
||||||||||||||||||||||
Restricted
stock grants and cancellations, net of amortization
|
31
|
--
|
108
|
--
|
--
|
--
|
--
|
108
|
||||||||||||||||||||||
Balance
as of April 30, 2007
|
23,809
|
$
|
238
|
$
|
72,612
|
$
|
83,290
|
$
|
(12,814
|
)
|
$
|
--
|
$
|
1,155
|
$
|
144,481
|
||||||||||||||
Net
income
|
--
|
--
|
--
|
14,504
|
--
|
--
|
--
|
14,504
|
||||||||||||||||||||||
Currency
translation adjustments
|
--
|
--
|
--
|
--
|
--
|
--
|
11,686
|
11,686
|
||||||||||||||||||||||
Unrealized
loss on securities, net of reclassification adjustment of $26
and
tax
of $(289)
|
--
|
--
|
--
|
--
|
--
|
--
|
(486
|
)
|
(486
|
)
|
||||||||||||||||||||
Change
in pension plans, net of tax of $1,059
|
--
|
--
|
--
|
--
|
--
|
--
|
(1,785
|
)
|
(1,785
|
)
|
||||||||||||||||||||
Comprehensive
income
|
23,919
|
|||||||||||||||||||||||||||||
Cumulative
effect of adoption of FIN 48
|
--
|
--
|
--
|
(2,368
|
)
|
--
|
--
|
--
|
(2,368
|
)
|
||||||||||||||||||||
Stock
issued to Directors
|
--
|
--
|
(323
|
)
|
--
|
666
|
--
|
--
|
343
|
|||||||||||||||||||||
Stock
issued under employee plans, net
|
216
|
2
|
1,381
|
--
|
--
|
--
|
--
|
1,383
|
||||||||||||||||||||||
Stock
based compensation expense
|
--
|
--
|
1,408
|
--
|
--
|
--
|
--
|
1,408
|
||||||||||||||||||||||
Restricted
stock grants and cancellations, net of amortization
|
275
|
3
|
394
|
--
|
--
|
--
|
--
|
397
|
||||||||||||||||||||||
Balance
as of April 30, 2008
|
24,300
|
$
|
243
|
$
|
75,472
|
$
|
95,426
|
$
|
(12,148
|
)
|
$
|
--
|
$
|
10,570
|
$
|
169,563
|
||||||||||||||
Net
income
|
--
|
--
|
--
|
2,236
|
--
|
--
|
--
|
2,236
|
||||||||||||||||||||||
Currency
translation adjustments
|
--
|
--
|
--
|
--
|
--
|
--
|
(25,709
|
)
|
(25,709
|
)
|
||||||||||||||||||||
Unrealized
gain on securities, net of reclassification adjustment of $2,423
and tax of $341
|
--
|
--
|
--
|
--
|
--
|
--
|
574
|
574
|
||||||||||||||||||||||
Change
in pension plans, net of tax of $1,172
|
--
|
--
|
--
|
--
|
--
|
--
|
(1,973
|
)
|
(1,973
|
)
|
||||||||||||||||||||
Change
in derivative instruments, net of
tax
of $440
|
--
|
--
|
--
|
--
|
--
|
--
|
(741
|
)
|
(741
|
)
|
||||||||||||||||||||
Comprehensive
loss
|
(25,613
|
)
|
||||||||||||||||||||||||||||
Stock
issued to Directors
|
--
|
--
|
(407
|
)
|
--
|
617
|
--
|
--
|
210
|
|||||||||||||||||||||
Stock
issued under employee plans, net
|
131
|
1
|
900
|
--
|
--
|
--
|
--
|
901
|
||||||||||||||||||||||
Stock
based compensation expense
|
--
|
--
|
2,032
|
--
|
--
|
--
|
--
|
2,032
|
||||||||||||||||||||||
Restricted
stock grants and cancellations, net of amortization
|
743
|
8
|
1,201
|
--
|
--
|
--
|
--
|
1,209
|
||||||||||||||||||||||
Balance
as of April 30, 2009
|
25,174
|
$
|
252
|
$
|
79,198
|
$
|
97,662
|
$
|
(11,531
|
)
|
$
|
--
|
$
|
(17,279
|
)
|
$
|
148,302
|
·
|
persuasive
evidence of an arrangement exists;
|
·
|
delivery
has occurred or services have been
rendered;
|
·
|
the
price is fixed or determinable; and
|
·
|
collectibility
is reasonably assured
|
·
|
The equipment the Company
sells has value on a stand-alone basis. The Company's customers may
resell equipment on a stand-alone basis and there is an observable market
for the equipment. The Company also may sell the equipment
without installation, training or service agreements. In these cases, the
overall sales price is reduced by an amount equal to the fair value of any
undelivered elements, as
applicable.
|
·
|
There is objective and
reliable evidence of the fair value of the undelivered items, as
applicable. The Company calculates the fair value of these elements
based on the same, or similar, services provided to customers on a
stand-alone basis.
|
·
|
There are no general rights of
return relating to the equipment. The Company has no
obligation to accept the return of products sold other than for repair or
replacement of defective products, which must be authorized in
advance.
|
In
thousands
|
Balance
at
Beginning
of
Fiscal
Year
|
Charges
to
Costs
and
Expenses1
|
Deductions2
|
Balance
at
End
of
Fiscal
Year
|
||||||||||||
Fiscal
2009
|
$
|
6,384
|
$
|
2,733
|
$
|
(2,376
|
)
|
$
|
6,741
|
|||||||
Fiscal
2008
|
$
|
7,012
|
$
|
2,524
|
$
|
(3,152
|
)
|
$
|
6,384
|
|||||||
Fiscal
2007
|
$
|
7,016
|
$
|
2,829
|
$
|
(2,833
|
)
|
$
|
7,012
|
|
2
Deductions include accounts receivable written off and
recoveries.
|
April
30,
|
||||||||
In
thousands
|
2009
|
2008
|
||||||
Raw
materials and purchased parts
|
$
|
58,779
|
$
|
64,230
|
||||
Work
in process
|
1,847
|
2,894
|
||||||
Finished
goods
|
11,482
|
9,803
|
||||||
Total
inventories
|
$
|
72,108
|
$
|
76,927
|
April
30,
|
||||||||
In
thousands
|
2009
|
2008
|
||||||
Land
|
$
|
1,020
|
$
|
1,218
|
||||
Buildings
|
35,166
|
38,405
|
||||||
Machinery,
tools and equipment
|
96,457
|
109,530
|
||||||
132,643
|
149,153
|
|||||||
Accumulated
depreciation
|
(101,091
|
)
|
(113,081
|
)
|
||||
31,552
|
36,072
|
|||||||
Construction
in progress
|
5,567
|
3,780
|
||||||
Total
property, plant and equipment, net
|
$
|
37,119
|
$
|
39,852
|
In
thousands
|
October
21, 2008
|
|||
Assets
acquired:
|
||||
Cash
and cash equivalents
|
$
|
4,128 | ||
Accounts
receivable
|
6,940 | |||
Inventories
|
8,756 | |||
Prepaid
and other assets
|
615 | |||
Property,
plant and equipment
|
1,831 | |||
Goodwill
|
16,009 | |||
Deferred
tax assets
|
3,030 | |||
Other
assets
|
3,135 | |||
Total
assets acquired
|
$ | 44,444 | ||
Liabilities
assumed:
|
||||
Accounts
payable
|
$ | 2,499 | ||
Accrued
compensation and benefits
|
2,954 | |||
Other
liabilities
|
5,579 | |||
Deferred
revenue
|
959 | |||
Total
liabilities assumed
|
$ | 11,991 | ||
Net
assets acquired
|
$ | 32,453 |
In
thousands
|
May
1, 2007
|
|||
Assets
acquired:
|
||||
Cash
and cash equivalents
|
$
|
500
|
||
Accounts
receivable
|
701
|
|||
Inventories
|
2,106
|
|||
Prepaid
expenses and other current assets
|
71
|
|||
Property,
plant and equipment
|
450
|
|||
Goodwill
|
5,954
|
|||
Other
assets
|
68
|
|||
Total
assets acquired
|
$
|
9,850
|
||
Liabilities
assumed:
|
||||
Accounts
payable
|
$
|
1,447
|
||
Accrued
compensation and benefits
|
139
|
|||
Other
accrued liabilities
|
841
|
|||
Deferred
revenue
|
1,038
|
|||
Deferred
income taxes
|
223
|
|||
Long-term
debt
|
1,012
|
|||
Total
liabilities assumed
|
$
|
4,700
|
||
Net
assets acquired
|
$
|
5,150
|
April
30, 2009
|
April
30, 2008
|
|||||||||||||||
In
thousands
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
Gross
Carrying
Amount
|
Accumulated
Amortization
|
||||||||||||
Amortized
intangible assets:
|
||||||||||||||||
Patents
|
$
|
7,603
|
$
|
3,210
|
$
|
7,512
|
$
|
3,062
|
||||||||
Other
|
5,131
|
739
|
646
|
413
|
||||||||||||
Total
amortized intangible assets
|
$
|
12,734
|
$
|
3,949
|
$
|
8,158
|
$
|
3,475
|
In
thousands
|
Sign
Making
&
Specialty
Graphics
|
Apparel
&
Flexible
Materials
|
Ophthalmic
Lens
Processing
|
Total
|
||||||||||||
Balance
as of April 30, 2007
|
$
|
23,923
|
$
|
13,906
|
$
|
16,996
|
$
|
54,825
|
||||||||
Business
acquisition
|
5,862
|
25
|
---
|
5,887
|
||||||||||||
Effects
of currency translation
|
914
|
218
|
---
|
1,132
|
||||||||||||
Balance
as of April 30, 2008
|
$
|
30,699
|
$
|
14,149
|
$
|
16,996
|
$
|
61,844
|
||||||||
Business
acquisitions
|
---
|
20,245
|
---
|
20,245
|
||||||||||||
Adjustment
to previously reported goodwill
|
92
|
---
|
---
|
92
|
||||||||||||
Effects
of currency translation
|
(5,054
|
)
|
(187
|
)
|
---
|
(5,241
|
)
|
|||||||||
Balance
as of April 30, 2009
|
$
|
25,737
|
$
|
34,207
|
$
|
16,996
|
$
|
76,940
|
For
the Fiscal Years Ended April 30,
|
||||||||||||||||||||||||
2009
|
2008
|
|||||||||||||||||||||||
In
thousands
|
Cost
|
Unrealized
Gains
|
Estimated
Fair
Value
|
Cost
|
Unrealized
Losses
|
Estimated
Fair
Value
|
||||||||||||||||||
Mutual
funds
|
$
|
2,796
|
$
|
159
|
$
|
2,955
|
$
|
5,461
|
$
|
(756
|
)
|
$
|
4,705
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
In
thousands
|
2009
|
2008
|
2007
|
|||||||||
Current:
|
||||||||||||
Federal
|
$
|
(270
|
)
|
$
|
(1,602
|
)
|
$
|
(232
|
)
|
|||
State
and local
|
95
|
273
|
223
|
|||||||||
Foreign
|
1,979
|
6,406
|
4,805
|
|||||||||
Total
current
|
1,804
|
5,077
|
4,796
|
|||||||||
Deferred:
|
||||||||||||
Federal
|
(3,134
|
)
|
900
|
1,521
|
||||||||
State
and local
|
(106
|
)
|
128
|
278
|
||||||||
Foreign
|
(2,501
|
)
|
143
|
523
|
||||||||
Total
deferred
|
(5,741
|
)
|
1,171
|
2,322
|
||||||||
Income
tax expense
|
$
|
(3,937
|
)
|
$
|
6,248
|
$
|
7,118
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Statutory
U.S. federal income tax rate
|
35.0
|
%
|
35.0
|
%
|
35.0
|
%
|
||||||
State
income taxes, net of US federal tax benefit
|
(3.7
|
)
|
1.3
|
1.5
|
||||||||
Reversal
of valuation allowance in France
|
190.7
|
---
|
---
|
|||||||||
Foreign
tax differences and other valuation allowance adjustments
|
(47.2
|
)
|
1.0
|
1.9
|
||||||||
Export
tax incentives
|
---
|
---
|
(1.3
|
)
|
||||||||
Research
and development tax credits
|
20.9
|
|
(2.0
|
)
|
(2.8
|
)
|
||||||
Adjustment
of prior years' tax estimates
|
34.0
|
|
(7.0
|
)
|
(0.6
|
)
|
||||||
Other,
net
|
1.8
|
1.8
|
0.8
|
|||||||||
Effective
income tax rate
|
231.5
|
%
|
30.1
|
%
|
34.5
|
%
|
April
30, 2009
|
April
30, 2008
|
|||||||||||||
In
thousands
|
Deferred
Tax
Assets
|
Deferred
Tax
Liabilities
|
Deferred
Tax
Assets
|
Deferred
Tax
Liabilities
|
||||||||||
Depreciation
|
$
|
1,452
|
$
|
1,265
|
$
|
1,332
|
$
|
1,704
|
||||||
Patents
|
---
|
1,519
|
---
|
1,517
|
||||||||||
Employee
benefit plans
|
12,097
|
154
|
11,935
|
95
|
||||||||||
Inventory
|
5,639
|
---
|
3,641
|
---
|
||||||||||
Asset
valuations
|
13,734
|
6,799
|
13,570
|
5,815
|
||||||||||
Provisions
for estimated expenses
|
3,442
|
---
|
3,262
|
73
|
||||||||||
Net
operating losses
|
23,902
|
---
|
16,584
|
---
|
||||||||||
Credit
carryforwards
|
7,133
|
270
|
5,137
|
---
|
||||||||||
Other
|
1,843
|
805
|
1,789
|
550
|
||||||||||
69,242
|
10,812
|
57,250
|
9,754
|
|||||||||||
Valuation
allowance
|
(17,752
|
)
|
---
|
(16,144
|
)
|
---
|
||||||||
$
|
51,490
|
$
|
10,812
|
$
|
41,106
|
$
|
9,754
|
For
the Fiscal Years Ended April 30,
|
|||||||||||
In
thousands
|
2009
|
2008
|
2007
|
||||||||
United
States
|
$
|
(11,963
|
)
|
$
|
439
|
$
|
4,489
|
||||
Foreign
|
10,262
|
20,313
|
16,137
|
||||||||
Income
before income taxes
|
$
|
(1,701
|
)
|
$
|
20,752
|
$
|
20,626
|
In
thousands
|
Balance
at
Beginning
of
Fiscal
Year
|
Charges
to
Income
Tax
Expense
|
Acquired
Valuation
Allowances
|
Deductions
|
1
|
Balance
at
End
of
Fiscal
Year
|
||||||||||||||
Fiscal
2009
|
$
|
16,144
|
$
|
1,511
|
$
|
3,415
|
$
|
(3,318
|
)
|
$
|
17,752
|
|||||||||
Fiscal
2008
|
$
|
15,043
|
$
|
1,188
|
$
|
---
|
$
|
(87
|
)
|
$
|
16,144
|
|||||||||
Fiscal
2007
|
$
|
14,292
|
$
|
1,227
|
$
|
---
|
$
|
(476
|
)
|
$
|
15,043
|
In
thousands
|
2009
|
2008
|
||||||
Beginning
balance
|
$
|
4,064
|
$
|
5,061
|
||||
Additions
for tax positions related to the current year
|
140
|
74
|
||||||
Additions
for tax positions of prior years
|
37
|
292
|
||||||
Reductions
for tax positions of prior years
|
(196
|
)
|
(374
|
)
|
||||
Reductions
for lapse of applicable statutes of limitation
|
(623
|
)
|
(989
|
)
|
||||
Settlements
|
---
|
---
|
||||||
Ending
balance
|
$
|
3,422
|
$
|
4,064
|
April
30, 2009
|
April
30,
|
|||||||||||
In
thousands
|
Effective
rates
|
2009
|
2008
|
|||||||||
Short-term
lines of credit
|
4.67
|
%
|
$
|
189
|
$
|
---
|
||||||
Revolving
credit facility
|
5.33
|
%
|
67,500
|
36,000
|
||||||||
Industrial
development bonds
|
3.15
|
%
|
6,000
|
6,000
|
||||||||
73,689
|
42,000
|
|||||||||||
Less
portion due within one year
|
(189
|
)
|
---
|
|||||||||
Total
long-term debt
|
$
|
73,500
|
$
|
42,000
|
Total
Funded Debt to Consolidated EBITDA Ratio
|
ABR
Margin
(basis
points)
|
LIBOR
Margin
(basis
points)
|
Commitment
Fee (basis points)
|
|||||||||
3.00x
and greater
|
300.0 | 400.0 | 50.0 | |||||||||
2.25x
to less than 3.00x
|
225.0 | 325.0 | 50.0 | |||||||||
1.50x
to less than 2.25x
|
175.0 | 275.0 | 37.5 | |||||||||
0.75x
to less than 1.50x
|
137.5 | 237.5 | 25.0 | |||||||||
Less
than 0.75x
|
100.0 | 200.0 | 25.0 |
In
thousands
|
Balance
Sheet Location
|
Liabilities
|
|||
Derivatives
designated as hedging instruments:
|
|||||
Interest
rate swap arrangements
|
Other
accrued liabilities
|
$ | 1,181 |
In
thousands
|
2009
|
|||
Loss
recognized in Accumulated Other Comprehensive Income (Loss) in
Shareholders' Equity before tax effect
|
$ | 1,181 | ||
Loss
reclassified from Accumulated Other Comprehensive Income (Loss) in
Shareholders' Equity to Interest
Expense
(effective portion)
|
$ | 301 |
For
the Fiscal Years Ended April 30,
|
|||||
2009
|
2008
|
2007
|
|||
Expected
option term1
|
5.5
years
|
5.9
years
|
5.6
years
|
||
Expected
volatility2
|
46.3%
|
51%
|
55%
|
||
Risk-free
interest rate3
|
3.0%
|
3.2%
|
4.4%
|
||
1
|
The
option term was determined using the simplified method for estimating
expected option life through December 31, 2007. The Company's
options qualify as "plain-vanilla" options, as defined in the SEC's Staff
Accounting Bulletin No. 107, "Share-Based Payment." Beginning
on January 1, 2008, the expected option term is determined by analyzing
the Company's historical experience.
|
||||
2
|
The
stock volatility for each grant is measured using the weighted-average of
historical daily price changes of the Company's common stock over the most
recent period equal to the expected option life of the
grant.
|
||||
3
|
The
risk-free interest rate is based on the 5-year U.S. Treasury note
yield in effect at the time of grant.
|
Shares
(in Thousands)
|
Weighted-
average
Exercise
Price
|
Weighted-
average
Remaining
Contractual
Term
|
Aggregate
Intrinsic
Value
(in
millions)
|
||||||||||
Outstanding
as of April 30, 2008
|
2,117
|
$
|
10.42
|
5.8
years
|
$
|
2.0
|
|||||||
Options
granted
|
402
|
$
|
8.49
|
||||||||||
Options
exercised
|
(139
|
)
|
$
|
6.84
|
$
|
0.6
|
|||||||
Options
canceled
|
(192
|
)
|
$
|
15.74
|
|||||||||
Outstanding
as of April 30, 2009
|
2,188
|
$
|
9.81
|
5.6
years
|
$
|
0.1
|
|||||||
Options
exercisable as of April 30, 2009
|
1,391
|
$
|
9.77
|
4.0
years
|
$
|
0.1
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
2009
|
2008
|
2007
|
||||||||||
Restricted
stock awarded (shares in thousands)
|
767
|
288
|
32
|
|||||||||
Weighted-average
fair value on date of grant per share
|
$
|
4.52
|
$
|
9.65
|
$
|
14.06
|
In
thousands except per share amounts
|
Shares
|
Weighted-average
Fair
Value
|
||||||
Nonvested
as of April 30, 2008
|
308
|
$
|
9.91
|
|||||
Granted
|
767
|
4.52
|
||||||
Vested
|
(73
|
)
|
10.01
|
|||||
Forfeited
|
(24
|
)
|
9.05
|
|||||
Nonvested
as of April 30, 2009
|
978
|
$
|
5.70
|
In
thousands
|
Foreign
Currency Translation Adjustment
|
Unrealized
Gain (Loss) on Available for Sale Securities
|
Net
Loss on Derivative Instruments
|
Minimum
Pension Liability Adjustment
|
Accumulated
Other Comprehensive (Loss) Income
|
||||||||||||
Balance
as of April 30, 2006
|
$
|
7,169
|
$
|
474
|
$
|
---
|
$
|
(5,749
|
)
|
$
|
1,894
|
||||||
Fiscal
2007 activity
|
7,266
|
(462
|
)
|
---
|
1,384
|
8,188
|
|||||||||||
Initial
application of SFAS 158
|
---
|
---
|
---
|
(8,927
|
)
|
(8,927
|
)
|
||||||||||
Balance
as of April 30, 2007
|
14,435
|
12
|
---
|
(13,292
|
)
|
1,155
|
|||||||||||
Fiscal
2008 activity
|
11,686
|
(486
|
)
|
---
|
(1,785
|
)
|
9,415
|
||||||||||
Balance
as of April 30, 2008
|
26,121
|
(474
|
)
|
---
|
(15,077
|
)
|
10,570
|
||||||||||
Fiscal
2009 activity
|
(25,709
|
)
|
574
|
(741
|
)
|
(1,973
|
)
|
(27,849
|
)
|
||||||||
Balance
as of April 30, 2009
|
$
|
412
|
$
|
100
|
$
|
(741
|
)
|
$
|
(17,050
|
)
|
$
|
(17,279
|
)
|
Qualified Plan
|
Nonqualified Plan
|
||||||||||||||
In
thousands
|
2009
|
2008
|
2009
|
2008
|
|||||||||||
Change
in benefit obligation:
|
|||||||||||||||
Benefit
obligation at beginning of fiscal year
|
$
|
103,992
|
$
|
104,175
|
$
|
7,256
|
$
|
7,274
|
|||||||
Service
cost
|
2,289
|
2,493
|
98
|
95
|
|||||||||||
Interest
cost
|
6,622
|
6,066
|
458
|
396
|
|||||||||||
Actuarial
(gain) loss
|
(10,080
|
)
|
(4,799
|
)
|
(362
|
)
|
73
|
||||||||
Benefits
paid
|
(4,151
|
)
|
(3,943
|
)
|
(513
|
)
|
(582
|
)
|
|||||||
Impact
of curtailment
|
(9,060
|
)
|
---
|
(329
|
)
|
---
|
|||||||||
Benefit
obligation at end of fiscal year
|
$
|
89,612
|
$
|
103,992
|
$
|
6,608
|
$
|
7,256
|
|||||||
Change
in plan assets:
|
|||||||||||||||
Fair
value of plan assets at beginning of year
|
$
|
82,197
|
$
|
82,142
|
$
|
---
|
$
|
---
|
|||||||
Actual
return on plan assets
|
(17,918
|
)
|
(1,442
|
)
|
---
|
---
|
|||||||||
Employer
contributions
|
5,906
|
5,440
|
513
|
582
|
|||||||||||
Benefits
paid
|
(4,151
|
)
|
(3,943
|
)
|
(513
|
)
|
(582
|
)
|
|||||||
Fair
value of plan assets at end of fiscal year
|
$
|
66,034
|
$
|
82,197
|
$
|
---
|
$
|
---
|
|||||||
Funded
status
|
$
|
(23,578
|
)
|
$
|
(21,795
|
)
|
$
|
(6,608
|
)
|
$
|
(7,256
|
)
|
|||
Amounts
recognized in balance sheets, before taxes:
|
|||||||||||||||
Other
accrued liabilities
|
$
|
---
|
$
|
---
|
$
|
(557
|
)
|
$
|
(544
|
)
|
|||||
Accrued
pension benefit liability
|
(23,578
|
)
|
(21,795
|
)
|
(6,051
|
)
|
(6,712
|
)
|
|||||||
Net
amount recognized
|
$
|
(23,578
|
)
|
$
|
(21,795
|
)
|
$
|
(6,608
|
)
|
$
|
(7,256
|
)
|
|||
Amounts recognized in
Accumulated Other Comprehensive Income (Loss), before taxes, consist
of:
|
|||||||||||||||
Net
actuarial loss
|
$
|
26,679
|
$
|
22,032
|
$
|
492
|
$
|
1,225
|
|||||||
Prior
service cost (credit)
|
---
|
803
|
---
|
(34
|
)
|
||||||||||
Net
amount recognized
|
$
|
26,679
|
$
|
22,835
|
$
|
492
|
$
|
1,191
|
Qualified Plan
|
Nonqualified Plan
|
|||||||||||||||
In
thousands
|
2009
|
2008
|
2009
|
2008
|
||||||||||||
Projected
benefit obligation
|
$
|
89,612
|
$
|
103,992
|
$
|
6,608
|
$
|
7,256
|
||||||||
Accumulated
benefit obligation
|
$
|
89,612
|
$
|
94,233
|
$
|
6,608
|
$
|
6,900
|
||||||||
Fair
value of plan assets
|
$
|
66,034
|
$
|
82,197
|
---
|
---
|
Qualified Plan
|
Nonqualified Plan
|
|||||||||||||||||||||||
For
the Fiscal Years Ended April 30,
|
For
the Fiscal Years Ended April 30,
|
|||||||||||||||||||||||
In
thousands
|
2009
|
2008
|
2007
|
2009
|
2008
|
2007
|
||||||||||||||||||
Service
cost
|
$
|
2,289
|
$
|
2,493
|
$
|
2,361
|
$
|
98
|
$
|
95
|
$
|
93
|
||||||||||||
Interest
cost
|
6,622
|
6,066
|
5,874
|
458
|
396
|
427
|
||||||||||||||||||
Expected
return on plan assets
|
(6,838
|
)
|
(7,044
|
)
|
(6,132
|
)
|
---
|
---
|
---
|
|||||||||||||||
Amortization
of:
Prior service cost (credit)
|
296
|
296
|
296
|
(3
|
)
|
(3
|
)
|
(2
|
)
|
|||||||||||||||
Actuarial
loss
|
970
|
614
|
730
|
42
|
4
|
22
|
||||||||||||||||||
Curtailment
loss (gain)
|
507
|
---
|
---
|
(32
|
)
|
---
|
---
|
|||||||||||||||||
Net
periodic benefit cost
|
$
|
3,846
|
$
|
2,425
|
$
|
3,129
|
$
|
563
|
$
|
492
|
$
|
540
|
In
thousands
|
Qualified Plan
|
Nonqualified Plan
|
||||||
Current
year actuarial loss (gain)
|
$
|
14,677
|
$
|
(362
|
)
|
|||
Amortization
of net actuarial loss
|
(970
|
)
|
(42
|
)
|
||||
Amortization
of prior service (cost) credit
|
(296
|
)
|
3
|
|||||
Effect
of curtailment:
|
||||||||
Curtailment
gain in other comprehensive income
|
(9,060
|
)
|
(330
|
)
|
||||
Unrecognized
prior service (cost) credit
|
(507
|
)
|
32
|
|||||
Total
recognized in other comprehensive income
|
$
|
3,844
|
$
|
(699
|
)
|
In
thousands
|
Qualified Plan
|
Nonqualified Plan
|
||||||
Net
actuarial loss
|
$
|
611
|
$
|
---
|
Qualified
Plan
|
Nonqualified
Plan
|
|||||||||||||||
Benefit
Obligation Assumptions
|
2009
|
2008
|
2009
|
2008
|
||||||||||||
Discount
rate
|
7.25
|
%
|
6.50
|
%
|
7.25
|
%
|
6.50
|
%
|
||||||||
Rate
of compensation increase
|
*
|
4.00
|
%
|
*
|
4.00
|
%
|
Qualified Plan
|
Nonqualified Plan
|
|||||||||||||||||||||||
For
the fiscal years ended April 30,
|
For
the fiscal years ended April 30,
|
|||||||||||||||||||||||
Net
Cost Assumptions
|
2009
|
2008
|
2007
|
2009
|
2008
|
2007
|
||||||||||||||||||
Discount
rate
|
6.50
|
%
|
6.00
|
%
|
6.25
|
%
|
6.50
|
%
|
6.00
|
%
|
6.25
|
%
|
||||||||||||
Expected
return on plan assets
|
8.25
|
%
|
8.50
|
%
|
8.50
|
%
|
---
|
---
|
---
|
|||||||||||||||
Rate
of compensation increase
|
4.00
|
%
|
4.00
|
%
|
4.00
|
%
|
4.00
|
%
|
4.00
|
%
|
4.00
|
%
|
2009
|
2008
|
|||||||
Equity
securities
|
51
|
%
|
53
|
%
|
||||
Debt
securities
|
40
|
%
|
39
|
%
|
||||
Real
estate
|
5
|
%
|
5
|
%
|
||||
Other
(primarily money market funds)
|
4
|
%
|
3
|
%
|
||||
100
|
%
|
100
|
%
|
In
thousands
|
Qualified
Plan
|
Nonqualified
Plan
|
||||||
Fiscal
Year 2010
|
$
|
4,414
|
$
|
557
|
||||
Fiscal
Year 2011
|
$
|
4,588
|
$
|
554
|
||||
Fiscal
Year 2012
|
$
|
4,790
|
$
|
551
|
||||
Fiscal
Year 2013
|
$
|
5,182
|
$
|
555
|
||||
Fiscal
Year 2014
|
$
|
5,414
|
$
|
550
|
||||
Fiscal
Years 2015-2019
|
$
|
30,984
|
$
|
2,846
|
For
the Fiscal Years Ended April 30,
|
||||||||
In
thousands
|
2009
|
2008
|
||||||
Beginning
balance
|
$
|
2,327
|
$
|
2,337
|
||||
Warranties
issued in the current period
|
5,036
|
5,880
|
||||||
Impact
of business acquisitions (See Note 5)
|
669
|
---
|
||||||
Reductions
for costs incurred
|
(5,217
|
)
|
(5,890
|
)
|
||||
Ending
balance
|
$
|
2,815
|
$
|
2,327
|
Level 2
|
Quoted
prices for similar assets or liabilities in active markets or inputs that
are observable for the asset or liability, either directly or indirectly
through market corroboration, for substantially the full term of the
financial instrument.
|
In
thousands
|
Total
|
Quoted
prices
in
active
markets
(Level
1)
|
Significant
other
observable
inputs
(Level
2)
|
Significant
unobservable
inputs
(Level
3)
|
||||||||||||
Interest
rate swap agreements
|
$
|
(1,181
|
)
|
$
|
---
|
$
|
(1,181
|
)
|
$
|
---
|
||||||
Available
for sale investments
|
2,955
|
2,955
|
---
|
---
|
||||||||||||
Total
|
$
|
1,774
|
$
|
2,955
|
$
|
(1,181
|
)
|
$
|
---
|
For
the Fiscal Years Ended April 30,
|
||||||||||||
In
thousands
|
2009
|
2008
|
2007
|
|||||||||
Sign
Making and Specialty Graphics:
|
||||||||||||
Gerber
Scientific Products
|
$
|
89,712
|
$
|
102,689
|
$
|
89,357
|
||||||
Spandex
|
230,993
|
258,397
|
212,730
|
|||||||||
Sign
Making and Specialty Graphics
|
320,705
|
361,086
|
302,087
|
|||||||||
Apparel
and Flexible Materials
|
174,566
|
207,945
|
196,164
|
|||||||||
Ophthalmic
Lens Processing
|
57,543
|
70,986
|
76,547
|
|||||||||
Consolidated
revenue
|
$
|
552,814
|
$
|
640,017
|
$
|
574,798
|
||||||
Sign
Making and Specialty Graphics:
|
||||||||||||
Gerber
Scientific Products
|
$
|
(1,741
|
)
|
$
|
1,376
|
$
|
5,199
|
|||||
Spandex
|
9,559
|
10,592
|
6,419
|
|||||||||
Sign
Making and Specialty Graphics
|
7,818
|
11,968
|
11,618
|
|||||||||
Apparel
and Flexible Materials
|
12,059
|
26,681
|
27,601
|
|||||||||
Ophthalmic
Lens Processing
|
3,198
|
4,384
|
2,913
|
|||||||||
Segment
operating income
|
23,075
|
43,033
|
42,132
|
|||||||||
Corporate
operating expenses
|
(16,840
|
)
|
(17,984
|
)
|
(18,500
|
)
|
||||||
Total
operating income
|
$
|
6,235
|
$
|
25,049
|
$
|
23,632
|
In
thousands
|
United
States
|
Europe
|
All
Other
|
Total
|
||||||||||||
2009
|
||||||||||||||||
Revenue
|
$
|
175,114
|
$
|
248,524
|
$
|
129,176
|
$
|
552,814
|
||||||||
Property,
plant and equipment
|
$
|
19,020
|
$
|
15,101
|
$
|
2,998
|
$
|
37,119
|
||||||||
2008
|
||||||||||||||||
Revenue
|
$
|
163,099
|
$
|
292,252
|
$
|
184,666
|
$
|
640,017
|
||||||||
Property,
plant and equipment
|
$
|
18,440
|
$
|
17,986
|
$
|
3,426
|
$
|
39,852
|
||||||||
2007
|
||||||||||||||||
Revenue
|
$
|
157,600
|
$
|
243,564
|
$
|
173,634
|
$
|
574,798
|
||||||||
Property,
plant and equipment
|
$
|
16,775
|
$
|
17,554
|
$
|
2,653
|
$
|
36,982
|
In
thousands
|
Building
and
Office
Space
|
Machinery
and
Equipment
|
Total
|
|||||||||
2010
|
$
|
10,337
|
$
|
1,362
|
$
|
11,699
|
||||||
2011
|
8,441
|
860
|
9,301
|
|||||||||
2012
|
7,322
|
422
|
7,744
|
|||||||||
2013
|
6,349
|
86
|
6,435
|
|||||||||
2014
|
5,783
|
---
|
5,783
|
|||||||||
After
2014
|
18,449
|
---
|
18,449
|
|||||||||
$
|
56,681
|
$
|
2,730
|
$
|
59,411
|
April
30, 2009
|
April
30, 2008
|
April
30, 2007
|
||||||||||||||||||||||||||||||||||
In
thousands except per share amounts
|
Net
Income
|
Average
Shares
|
Per
Share
|
Net
Income
|
Average
Shares
|
Per
Share
|
Net
Income
|
Average
Shares
|
Per
Share
|
|||||||||||||||||||||||||||
Basic
earnings per share
|
$
|
2,236
|
23,561
|
$
|
0.09
|
$
|
14,504
|
23,320
|
$
|
0.62
|
$
|
13,508
|
22,896
|
$
|
0.59
|
|||||||||||||||||||||
Effect
of dilutive options and awards
|
---
|
112
|
---
|
---
|
278
|
(0.01
|
)
|
---
|
550
|
(0.01
|
)
|
|||||||||||||||||||||||||
Diluted
earnings per share
|
$
|
2,236
|
23,673
|
$
|
0.09
|
$
|
14,504
|
23,598
|
$
|
0.61
|
$
|
13,508
|
23,446
|
$
|
0.58
|
In
thousands except per share amounts
|
First
Quarter
|
Second
Quarter
|
Third
Quarter
|
Fourth
Quarter
|
||||||||||||
Fiscal
2009
|
||||||||||||||||
Revenue
|
$
|
158,858
|
$
|
153,758
|
$
|
120,097
|
$
|
120,101
|
||||||||
Gross
profit
|
$
|
42,044
|
$
|
43,594
|
$
|
35,519
|
$
|
33,221
|
||||||||
Net
income (loss)
|
$
|
681
|
$
|
6,094
|
$
|
(2,232
|
)
|
$
|
(2,307
|
)
|
||||||
Earnings
(Loss) per common share:
|
||||||||||||||||
Basic
|
$
|
0.03
|
$
|
0.26
|
$
|
(0.09
|
)
|
$
|
(0.10
|
)
|
||||||
Diluted
|
$
|
0.03
|
$
|
0.26
|
$
|
(0.09
|
)
|
$
|
(0.10
|
)
|
||||||
Fiscal
2008
|
||||||||||||||||
Revenue
|
$
|
153,667
|
$
|
160,716
|
$
|
151,966
|
$
|
173,668
|
||||||||
Gross
profit
|
$
|
45,461
|
$
|
46,396
|
$
|
43,453
|
$
|
51,223
|
||||||||
Net
income
|
$
|
2,837
|
$
|
2,501
|
$
|
3,063
|
$
|
6,103
|
||||||||
Earnings
per common share:
|
||||||||||||||||
Basic
|
$
|
0.12
|
$
|
0.11
|
$
|
0.13
|
$
|
0.26
|
||||||||
Diluted
|
$
|
0.12
|
$
|
0.11
|
$
|
0.13
|
$
|
0.26
|
GERBER SCIENTIFIC,
INC.
|
|||
(Registrant)
|
|||
July
7, 2009
|
By:
|
/s/ John J.
Krawczynski
|
|
John
J. Krawczynski
(Duly
Authorized Officer and Principal Accounting
Officer)
|
Date
|
Signature
|
Title
|
July
7, 2009
|
/s/ Marc T.
Giles
(Marc
T. Giles)
|
President,
Chief Executive Officer and Director (Principal Executive
Officer)
|
July
7, 2009
|
/s/ Michael R.
Elia
(Michael
R. Elia)
|
Executive
Vice President and Chief Financial Officer (Principal Financial
Officer)
|
July
7, 2009
|
/s/ Donald P.
Aiken
(Donald
P. Aiken)
|
Director,
Chairman
|
July
7, 2009
|
/s/ Edward G.
Jepsen
(Edward
G. Jepsen)
|
Director
|
July
7, 2009
|
/s/ Randall D.
Ledford
(Randall
D. Ledford)
|
Director
|
July
7, 2009
|
/s/ John R.
Lord
(John
R. Lord)
|
Director
|
July
7, 2009
|
/s/ Carole F. St.
Mark
(Carole
F. St. Mark)
|
Director
|
July
7, 2009
|
/s/ W. Jerome
Vereen
(W.
Jerome Vereen)
|
Director
|